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A B S T R A C T
Background
There are two main strategies for the prevention of post-abortal upper genital tract infection: antibiotics given around the time of
surgery for all women; and ’screen-and-treat’, in which all women presenting for abortion are screened for genital infections and those
with positive results are treated.
Objectives
To determine:
1. the effectiveness of antibiotic prophylaxis in preventing post-abortal upper genital tract infection;
2. the most effective antibiotic regimen;
3. the most effective strategy.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, EMBASE, POPLINE and LILACS. The
search was last updated in May 2011.
Selection criteria
Randomised controlled trials (RCTs) in any language including women undergoing induced first trimester surgical or medical abortion,
comparing: 1) any antibiotic regimen to placebo, nothing, or another antibiotic; 2) screen-and-treat versus antibiotics. The primary
outcome was the proportion of women diagnosed with post-abortal upper genital tract infection.
Data collection and analysis
Two reviewers independently selected references and extracted data. We calculated risk ratios (RR) with 95% confidence intervals (CI).
We used meta-analysis where appropriate and examined between trial heterogeneity using the I2 statistic. In the presence of between
trial heterogeneity we also estimated the 95% prediction interval (PI).
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Main results
A total of 703 unique items was identified. We included 19 RCTs. There was evidence of small study biases (Egger test, P = 0.002).
In 15 placebo-controlled RCTs there was an effect of antibiotic prophylaxis (pooled RR 0.59, 95% CI 0.46 to 0.75, 95% PI 0.30 to
1.14, I2 = 39%). There were insufficient data (three trials) to determine whether one regimen was superior to another. In one trial, the
incidence of post-abortal upper genital tract infection was higher in women allocated to the screen-and-treat strategy (RR 1.53, 95%
CI 0.99 to 2.36).
Authors’ conclusions
Antibiotic prophylaxis at the time of first trimester surgical abortion is effective in preventing post-abortal upper genital tract infection.
Evidence of between trial heterogeneity suggests that the effect might not apply to all settings, population groups or interventions.
This review did not determine the most effective antibiotic prophylaxis regimen. Antibiotic choice should take into account the local
epidemiology of genital tract infections, including sexually transmitted infections.
Further RCTs comparing different antibiotics or combinations of antibiotics with each other would be useful. Such trials could be done
in low and middle income countries and where the prevalence of genital tract infections in women presenting for abortion is high.
P L A I N L A N G U A G E S U M M A R Y
Antibiotic prophylaxis for first trimester induced abortion
Infection of the upper genital tract, including the uterus and fallopian tubes, can cause complications after induced abortion. Antibiotics
given around the time of the abortion (prophylaxis) could prevent this complication. We found 19 randomised controlled trials that
looked at the effect of antibiotic prophylaxis on post-abortal upper genital tract infection amongst women requesting induced abortion
in the first trimester of pregnancy. We looked at the effect of any antibiotic prophylaxis regimen on the outcome. Overall, the risk of
post-abortal upper genital tract infection in women receiving antibiotics was 59% that of women who received placebo. There were,
however, differences between the trial results over and above what would be expected by chance alone. It should be noted that, if the
infection is caused by a sexually transmitted organism, antibiotic prophylaxis will not protect the woman from becoming re-infected
if her sexual partner has not been treated. None of the trials was done in lower or middle income countries, which is where the risk
of post-abortal complications is highest. Further trials are needed to determine whether combinations of antibiotics can prevent more
infections than single antibiotics, or whether antibiotic prophylaxis should be restricted to women with positive results of screening
tests before the abortion.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
First author, year No. of patients analysed
for secondary outcome
(%, patients analysed for
primary outcome as de-
nominator)
Antibiotic
treatment within 6 weeks
after abortion
Hospitalisation due to in-
fectious complications
Adverse effects of antibi-
otics
Comparison: antibiotics vs placebo
Crowley 2001 n.r. n.r. 15 women readmitted in
total
n.r.
Darj 1987 769 (100%) n.r. n.r. Gastrointestinal problems
(nausea, vomiting), other
(unspecified)
Heisterberg 1985b 532 (100%) n.r. n.r. Gastrointestinal problems
(unspecified)
Heisterberg 1985c 12 (12%), only women de-
veloping post-abortal up-
per genital tract infection
analysed
Mean amount of antibiotic
per patient in intervention
arm: 5.9 g (metronidazole)
and 8.0 g (ampicillin) and
8.5 IU (penicillin)
Mean amount of antibiotic
per patient in control arm:
4.1 g (metronidazole) and
13.5 g (ampicillin) and 7.1
IU (penicillin)
Mean hospital days per pa-
tient in intervention arm: 6.
5 days
Mean hospital days per pa-
tient in control arm: 6.1
days
n.r.
Heisterberg 1987 14 (12%), only women de-
veloping post-abortal up-
per genital tract infection
analysed
n.r. n.r. No adverse events ob-
served.
Heisterberg 1988 9 (16%), only women de-
veloping post-abortal up-
per genital tract infection
analysed
Mean amount of antibiotic
per patient in intervention
arm: 5.0 g (metronidazole)
and 8.3 g (erythromycin)
Mean amount of antibiotic
per patient in control arm:
5.6 g (metronidazole) and
10.0 g (erythromycin)
Mean hospital days per pa-
tient in intervention arm: 6.
3 days
Mean hospital days per pa-
tient in control arm: 7.0
days
n.r.
Krohn 1981 17 (8%), only women de-
veloping post-abortal up-
per genital tract infection
analysed
n.r. One woman readmitted in
each arm
n.r.
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Krohn 1986 285 (100%) n.r. n.r. No adverse events ob-
served.
Larsson 1992 n.r. n.r. n.r. n.r.
Larsson 2000 n.r. n.r. n.r. n.r.
Levallois 1988 1077 (100%) n.r. n.r. Gastrointestinal problems
(vomiting, nausea, diar-
rhoea)
Nielsen 1993 1073 (100%) n.r. n.r. Gastrointestinal problems
(vomiting, nausea), hyper-
sensitivity reactions (skin ,
rash itching, tongue blis-
ters), pain
Sonne-Holm 1981 493 (100%) n.r. n.r. Hyper-
sensitivity reactions (rash)
, gastrointestinal problems
(unspecified)
Sorensen 1992 n.r. n.r. n.r. n.r.
Westrom 1981 n.r. n.r. n.r. n.r.
Comparison: antibiotics vs antibiotics
Caruso 2008 n.r. n.r. n.r. n.r.
Heisterberg 1986 13 (16%), only women de-
veloping post-abortal up-
per genital tract infection
analysed
Mean amount of antibiotic
per patient in intervention
arm: 9.6 g (metronidazole)
and 10.3 g (ampicillin), 1.
6 g (tetracycline) and 1.4 g
(erythromycin)
Mean amount of antibiotic
per patient in control arm:
7.3 g (metronidazole) and
7.9 g (ampicillin), 0.8 g
(tetracycline) and 0 g (ery-
thromycin)
Mean hospital days per pa-
tient in intervention arm: 2.
4 days
Mean hospital days per pa-
tient in control arm: 3.9
days
No adverse events ob-
served.
Lichtenberg 2003 n.r. n.r. n.r. n.r.
Comparison: universal antibiotic prophylaxis vs screen-and-treat-policy
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Penney 1998 1546 (96%), some women
lost to follow up
n.r. 16 women readmitted in
the arm with universal pro-
phylaxis
1 woman readmitted in the
arm with screen-and-treat-
policy
n.r.
n.r.: not reported
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
B A C K G R O U N D
Each year 210 million women become pregnant, of whom an
estimated 42 million have an induced abortion (WHO 2011).
Abortion causes 70,000 deaths and 4,652,171 Disability Adjusted
Life Years (DALYs) lost per year worldwide, the vast majority
due to unsafe abortions in developing countries. Thirteen per-
cent (47,000) of maternal deaths worldwide are due to unsafe
abortion and infections are a major contributor (WHO 2011),
Cervical instrumentation can introduce bacteria from the vagina
and cervix into the endometrial cavity, leading to post-abortal up-
per genital tract infection (Sawaya 1996). The terms post-abortal
pelvic infection (Levallois 1988) and post-abortal pelvic inflam-
matory disease (PID) (Heisterberg 1988b), have also been used
to describe this condition. Infectious agents associated with post-
abortal upper genital tract infection include exogenous bacteria,
endogenous vaginal anaerobes associated with bacterial vaginosis,
or sexually transmitted cervical pathogens (Neisseria gonorrhoeae
and Chlamydia trachomatis). The prevalence of endocervical C.
trachomatis in women presenting for abortion has been found to
be 13-14% amongst women screened using a nucleic acid amplifi-
cation test in abortion clinics in England in 1999-2000 (Pimenta
2003) and 2.9% in women undergoing legal abortion in Maputo,
Mozambique in 1991-1992, tested using direct immunofluores-
cence staining (Machungo 2002). Risk factors for post-abortal up-
per genital tract infection include a history of pelvic inflammatory
disease (PID) and the presence of a lower genital tract infection
due to N. gonorrhoeae, C. trachomatis or bacterial vaginosis at the
time of abortion (Heisterberg 1988b; Nielsen 1993). Post-abortal
upper genital tract infection is associated with short-termmorbid-
ity (Cameron 2002) and upper genital tract infections have long-
term sequelae in the form of chronic pelvic pain, dyspareunia, in-
fertility and ectopic pregnancy (Soper 2010).
Antibiotics given around the time of abortion should reduce the
risk of post-abortal upper genital tract infection. There is, however,
ongoing debate about the most effective strategy and antibiotic
regimen (Cameron 2002; Penney 1998). The possible approaches
that have been investigated so far are described below.
Antibiotic prophylaxis
Antibiotic prophylaxis is defined as the ’use of antibiotics be-
fore, during, or after a diagnostic, therapeutic, or surgical pro-
cedure to prevent infectious complications’ (National Centre for
Biotechnology Information 2010). For women undergoing abor-
tion, this means that they are given antibiotics around the time of
surgery even if they are not known to have a vaginal or cervical
infection. Universal prophylaxis means that all women are given
antibiotics, without carrying out tests for infection. The case in
favour of universal antibiotic prophylaxis was first made in a sys-
tematic review (Sawaya 1996). Sawaya et al. conducted a meta-
analysis of 12 randomised controlled trials (RCTs) published be-
tween 1966 and 1994 comparing antibiotics with placebo. They
reported a substantial reduction in the risk of post-abortal upper
genital tract infection in women receiving antibiotic prophylaxis
(relative risk, RR 0.58, 95% confidence intervals, CI 0.47 to 0.71,
fixed-effects meta-analysis) but there was substantial between-trial
heterogeneity in the results (reported as P < 0.001 for homogene-
ity). The authors concluded that there had been strong evidence
that antibiotics reduce the risk of post-abortal infection since 1986
and that further placebo-controlled trials should not be performed
(Sawaya 1996). Guidelines about the use of antibiotic prophylaxis
for abortion have since been published by several national guide-
line development groups (Achilles 2011; ACOG 2006; RCOG
2011; SIGN 2008).
Screen-and-treat
Screen-and-treat means that all women presenting for a termina-
tion of pregnancy are screened for genital infections. Those with
positive results are treated as soon as the results are known, prefer-
ably before the procedure. A screen-and-treat strategy for prevent-
ing post-abortal upper genital tract infection due to chlamydia has
been evaluated (Giertz 1987; Penney 1998). The major advantage
of the screen-and-treat strategy over universal antibiotic prophy-
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laxis is that, if the woman has a sexually transmitted infection,
partner notification and treatment can be done to reduce the risk
of re-infection from untreated sexual partners (Cameron 2002).
In addition, the screen-and-treat strategy avoids the unnecessary
administration of antibiotics to non-infected women and provides
an opportunity to screen for other sexually transmitted infections
and offer counselling (Cameron 2002). However, this strategy is
costly and requires more organisation than does universal prophy-
laxis. Timely provision of results is essential and, even then might
delay the procedure if the initial assessment and abortion take
place at the same visit. Furthermore, false negative screening test
results and infections not screened for can still put women at risk
of post-abortal infection (Penney 1998). The infections for which
women should be tested differs between settings. The low preva-
lence of gonorrhoea among women undergoing abortion in the
United Kingdom (approximately 0.2%) (Blackwell 1993) makes
screening in asymptomatic women controversial (Cameron 2002).
In contrast, the prevalence of bacterial vaginosis is high among
women requesting abortion, ranging from 17.5% (Penney 1998)
to 28% (Blackwell 1993). Furthermore, C. trachomatis is detected
more often in women with bacterial vaginosis and it may facili-
tate the carriage of chlamydia to the upper genital tract (Blackwell
1993). Combining preoperative screening with universal antibi-
otic prophylaxis could prevent both short-term morbidity and al-
low treatment of sexual partners of infectedwomen, but this would
increase costs to the health service even more.
An updated systematic review of the effects of antibiotic pro-
phylaxis in induced abortion provides opportunities to include
more recent trials and to address unanswered questions. These
may include differences in the effectiveness of antibiotics in trials
of women who are not screened for infections preoperatively and
those that excluded women with diagnosed infections: determin-
ing the optimal antibiotic regimen determining adverse effects and
examining the implications for re-infection in women who had a
sexually transmitted infection before the abortion.
O B J E C T I V E S
1. To determine the effectiveness of antibiotic prophylaxis in pre-
venting post-abortal upper genital tract infection.
2. To determine the most effective antibiotic regimen for prevent-
ing post-abortal upper genital tract infection.
3. To determine the most effective strategy for preventing post-
abortal upper genital tract infection by comparing universal an-
tibiotic prophylaxis with a screen and treat strategy, or with a com-
bination of screen-and-treat plus universal prophylaxis.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all RCTs published by May 2011 in any language.
Types of participants
All women undergoing induced first trimester surgical or medical
abortion with or without a history of PID, or a pre-abortion di-
agnosis of bacterial vaginosis, N. gonorrhoeae or C. trachomatis.
Types of interventions
1. Antibiotic prophylaxis:
a. any antibiotic regimen compared to a placebo or nothing. Both
local and systemic antibiotic regimens were included. Antibiotic
regimens that included preoperative, perioperative, postoperative
doses, or any combination of these were included;
b. any antibiotic regimen compared to another antibiotic regimen.
Both local and systemic antibiotic prophylaxis were included.
2. Screen-and-treat strategy:
a. universal antibiotic prophylaxis compared to a screen-and-treat
strategy and/or a combination of screen-and-treat and antibiotic
prophylaxis.
Types of outcome measures
1. The primary outcome was the proportion of women diagnosed
with post-abortal upper genital tract infection, according to the
definition used in the original trials.
2. Secondary outcomes were:
a. other antibiotic treatments provided in the six weeks following
the abortion;
b. hospitalisation due to infectious complications;
c. adverse effects of antibiotic prophylaxis or screening;
d. proportion of women undergoing the screen-and-treat strategy
who were re-infected with C. trachomatis.
Search methods for identification of studies
A comprehensive literature search was conducted to identify re-
ports describing universal antibiotic prophylaxis, the screen-and-
treat strategy and a combination of both strategies for first-
trimester abortion. Reference lists of relevant papers were screened
for additional, previously unidentified trials. The search was last
updated in May 2011. See Appendix 1 for search strategies used.
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Data collection and analysis
Study identification and data extraction
Two reviewers assessed the titles and abstracts as well as full-text
publications to determine eligibility. The same two reviewers used
a standardised form to extract data, in duplicate, for character-
istics of trials and patients, type of intervention and antibiotic
prophylaxis conducted, as well as number of women developing
post-abortal upper genital tract infection. Information about trial
characteristics that might be associated with bias in the effect es-
timates, including randomisation sequence generation, conceal-
ment of allocation, blinding, and exclusion of participants from
analysis after randomisation were also assessed, using criteria from
the Cochrane Handbook. Disagreements were resolved by discus-
sion with a third reviewer. We also contacted the trial authors to
request clarifications and obtain missing data. Entry of the data in
Review Manager software (RevMan 5) was double checked.
Data synthesis and analysis
We first conducted a descriptive synthesis of the trials and their
results and displayed the results in forest plots (RevMan 5).
• For the primary outcome we have used the term ’post-
abortal upper genital tract infection’, but in the summary of
characteristics of included studies we have given the name for the
primary outcome used by the trial authors, together with their
diagnostic criteria.
• For the intervention, we have used the general term
’antibiotic prophylaxis’. We used the term ’universal antibiotic
prophylaxis’ only if the trial report did not state that women
were tested for genital infections at baseline and that women
with positive results would be excluded or treated preoperatively.
We did not define a time limit on the duration of the antibiotic
regimen.
The results of individual trials are presented as the relative risk
(RR) with 95% confidence intervals (95% CI) of post-abortal
upper genital tract infection in women in the intervention group
compared to those in the control group.
To examine evidence for publication and small study biases we
drew funnel plots of log risk ratios against trial size (measured by
standard error of the log risk ratio) and did a statistical test for
asymmetry (Egger 1997).
Where appropriate, we pooled data using meta-analysis in Stata
(version 10, Stata Corporation, Austin, TX). We used the I-
squared statistic to estimate the approximate proportion of total
variability in point estimates that can be attributed to heterogene-
ity other than that due to chance (Higgins 2003). We explored
possible reasons for heterogeneity by stratifying study results ac-
cording to the characteristics of the study populations (e.g. history
of PID or chlamydia), the interventions (e.g. class of antibiotics
used, route of administration, etc.), or methodological character-
istics (adequate compared with inadequate random sequence gen-
eration, etc.). We also examined the role of methodological char-
acteristics on the effect estimate using meta-regression to estimate
the ratio of risk ratios. We used fixed-effects meta-analysis to es-
timate the common RR (95% CI), assuming that all or most be-
tween-trial variability is due to chance if there was little evidence
of between-trial heterogeneity (I2 < 25%). In the presence of be-
tween-trial heterogeneity (I2 = 25 to 75%) we used random-effects
meta-analysis (Der Simonian Laird model) to estimate the average
RR. In the text, we present both 95% CI, which express uncer-
tainty around the average effect, which is assumed to be normally
distributed, and the 95% prediction interval (PI), which takes into
account the whole distribution of the effects (Riley 2011). We did
not pool results if there was statistical evidence of severe between-
trial heterogeneity (I2 > 75%).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Figure 1 shows the flow diagram of studies identified and included
in the review. A total of 703 unique items was identified. The full
text of 36 potentially eligible publicationswas read. Sixteen articles
were excluded (Characteristics of excluded studies). Four articles
were excluded because the study population was not restricted to
womenundergoingfirst-trimester abortion (Cormier 1988;Giertz
1987;Miller 2004; Spence1982).One studywas excludedbecause
the outcome was bacteraemia after abortion and not upper genital
tract infection (Heisterberg 1985c). A trial by Henriques et al.
(Henriques 1994) was excluded because the women could not be
analysed in the groups to which they were randomised; a post-
randomisation risk assessment of women in the control group
was made and treatment adapted according to this evaluation.
We also excluded ten studies that were not RCTs (Bennett 2009;
Blackwell 1993; Chen 2007; Faucher 2006; Gemzell-Danielsson
2008; Grossmann 2008; Gupta 2007; May 2007; Nguyen 2009;
Prager 2009).
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Figure 1. Flow diagram.
8Perioperative antibiotics to prevent infection after first-trimester abortion (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Nineteen RCTs, reported in 20 publications (see Characteristics of
included studies), were included in the main dataset and descrip-
tive assessment of the prophylactic effect of antibiotics to prevent
postoperative pelvic infection inwomenundergoingfirst-trimester
abortion, compared with women receiving placebo, another an-
tibiotic, or a screen-and-treat strategy (Figure 2) (Caruso 2008;
Crowley 2001;Darj 1987;Heisterberg 1985a;Heisterberg 1985b;
Heisterberg 1986; Heisterberg 1987; Heisterberg 1988; Krohn
1981; Krohn 1986; Larsson 1992; Larsson 2000; Levallois 1988;
Lichtenberg 2003; Nielsen 1993; Penney 1998; Sonne-Holm
1981; Sorensen 1992; Westrom 1981). A total of 9715 women
was included, 660 of whom developed post-abortal upper genital
tract infection. One of the trials by Heisterberg and colleagues
was reported with earlier and later results. Both are listed under
Heisterberg 1986. We only include the results from the most re-
cent publication.
Figure 2. Effect of intervention on incidence of post-abortal upper genital tract infection, 19 trials: by
comparison
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We did not identify any RCTs that included women who had
undergone a medical abortion.
Of the 19 included RCTs, 15 compared antibiotic prophy-
laxis with administration of placebo (Crowley 2001; Darj
1987; Heisterberg 1985a; Heisterberg 1985b; Heisterberg 1987;
Heisterberg 1988; Krohn 1981; Krohn 1986; Larsson 1992;
Larsson 2000; Levallois 1988; Nielsen 1993; Sonne-Holm 1981;
Sorensen 1992; Westrom 1981). Three trials compared antibiotic
prophylaxis using one regimen in the intervention arm with an
alternative regimen (Heisterberg 1986; Lichtenberg 2003) or regi-
mens (Caruso 2008). One trial compared a screen-and-treat strat-
egy with universal antibiotic prophylaxis (Penney 1998).
The characteristics of included trials are shown below. Most
were conducted in Sweden (seven RCTs) (Darj 1987; Krohn
1981; Krohn 1986; Larsson 1992; Larsson 2000; Nielsen
1993; Westrom 1981) and Denmark (seven RCTs) (Heisterberg
1985a; Heisterberg 1985b; Heisterberg 1986; Heisterberg 1987;
Heisterberg 1988; Sonne-Holm 1981; Sorensen 1992). One
trial took place in each of the following countries: England
(Crowley 2001), Scotland (Penney 1998), Italy (Caruso 2008),
USA (Lichtenberg 2003) and Canada (Levallois 1988). No studies
were conducted in a low or middle income country.
Reporting of sexually transmitted infections, bacterial vagi-
nosis and history of PID at baseline and exclusions from study
population
In 15 of the 19 trials (Table 1), authors reported that women
had laboratory tests for at least one genital infection (Crowley
2001; Heisterberg 1985a; Heisterberg 1985b; Heisterberg 1986;
Heisterberg 1987; Heisterberg 1988; Krohn 1981; Krohn 1986;
Larsson 1992; Larsson 2000; Levallois 1988; Nielsen 1993;
Penney 1998; Sorensen 1992; Westrom 1981). In two trials au-
thors explicitly stated that no preoperative tests for infection were
done (Darj 1987; Lichtenberg 2003). In two trials there was no
mention of whether tests had been done or not (Caruso 2008;
Sonne-Holm 1981).
In 8 of the 19 trials, C. trachomatis was tested for in all women
at the baseline assessment; the percentage of women with a pos-
itive chlamydia test ranged from 1.9% (10/532) (Heisterberg
1985a) to 7.7% (21/273) (Crowley 2001). In two trials, women
with chlamydia were treated and excluded (Larsson 1992; Larsson
2000); in one trial, women with chlamydia were treated preoper-
atively (Crowley 2001); in one trial, in the first part of the trial,
women with chlamydia were treated after three weeks and in the
second part of the trial women with positive chlamydia tests were
excluded (Levallois 1988); in four trials the antibiotic regimens
were active against C. trachomatis (Heisterberg 1985a; Heisterberg
1988; Penney 1998; Sorensen 1992). In one further trial, some of
the women were tested for chlamydia, but the number of women
with positive results was not reported (Krohn 1986). In the other
11 trials, testing for C. trachomatis was not done.
In 14 trials, N. gonorrhoeae was tested for in all women at the
baseline visit: in 11 trials, women with gonorrhoea were treated
and excluded (Heisterberg 1985a; Heisterberg 1985b;Heisterberg
1986;Heisterberg 1987;Heisterberg 1988; Larsson 1992; Larsson
2000; Levallois 1988; Nielsen 1993; Sorensen 1992; Westrom
1981); in two trials there were no infected women (Crowley 2001;
Krohn1986); in one trial, infectedwomen (3/1613)were included
(Penney 1998). In the other five trials, testing for N. gonorrhoeae
was not done.
In six trials, testing for anaerobic organisms or bacterial vaginosis
was done: the percentage of women with bacterial vaginosis in
these trials ranged from 17% (220/1276 (Larsson 1992) and 282/
1613 (Penney 1998)) to 36% (41/115 (Heisterberg 1987)). In
two trials, only women with bacterial vaginosis were included (
Crowley2001; Larsson 1992); in three trials, womenwith bacterial
vaginosis were a part of the study population (Heisterberg 1985b;
Heisterberg 1987; Larsson 2000; Penney 1998). In the other 13
trials, testing for bacterial vaginosis was not done.
A history of PID was asked about in seven trials (Crowley 2001;
Heisterberg 1985b; Heisterberg 1986; Heisterberg 1988; Nielsen
1993; Sonne-Holm 1981; Sorensen 1992). The criteria for such
a diagnosis were reported in only one trial (antibiotics for PID
prescribed by a patient’s own doctor or a hospital) (Heisterberg
1986). The percentage of women reporting a history of PID was
4% (14/273) in one trial (Crowley 2001) but ranged from 21%
(164/769 (Darj 1987) and 105/493 (Sonne-Holm 1981)) to 29%
(308/1073 (Nielsen 1993)) in the other trials that recorded this
information.
Reporting of secondary outcomes
Summary of findings for the main comparison shows the studies
that assessed secondary outcomes. Three reported antibiotic treat-
ment provided within six weeks following abortion. All were con-
ducted byHeisterberg and colleagues and reported themean quan-
tity of antibiotics used per infected patient (Heisterberg 1985b;
Heisterberg 1986; Heisterberg 1988). None of the studies found
statistical evidence of a difference in the amount of antibiotics
administered for infection comparing the intervention with the
control group. Hospitalisation due to infectious complications
was assessed in six studies (Crowley 2001; Heisterberg 1985b;
Heisterberg 1986; Heisterberg 1988; Krohn 1981; Penney 1998).
Crowley et al. (Crowley 2001) reported the total number of
women readmitted to hospital, but did not provide their group al-
location. Krohn et al (Krohn 1981) found that in total two women
with post-abortal pelvic infection were readmitted to hospital; one
in each trial group. Heisterberg and colleagues assessed the mean
number of hospital days per infected women for the intervention
and control arms in three studies and found no statistical evi-
dence of differences between the two arms (Heisterberg 1985b;
Heisterberg 1986;Heisterberg 1988). Penney et al. (Penney 1998)
investigated the number of women who were readmitted to hospi-
tal within six weeks after abortion. They found that twice as many
women randomised to the screen-and-treat arm were readmitted
when compared with the prophylactic treatment group.
Adverse events of antibiotic prophylaxis were investigated in
eight trials (Darj 1987; Heisterberg 1985a; Heisterberg 1986;
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Heisterberg 1987; Krohn 1986; Levallois 1988; Nielsen 1993;
Sonne-Holm 1981); three did not report any adverse effects
(Heisterberg 1986; Heisterberg 1987; Krohn 1986). The most
common problems were gastrointestinal symptoms such as nau-
sea, vomiting and diarrhoea, as well as skin rash.
No studies reported the reinfection rate with C. trachomatis at
follow-up after first-trimester abortion.
Risk of bias in included studies
We assessed the risk of bias in all 19 included trials. In stratified
analyses, the assessments of trial characteristics were dichotomised,
comparing studies with either unclear or inadequate descriptions
with those that used adequate methods. Details of the risk of bias
assessed in all RCTs are shown with the Characteristics of included
studies and summarised in Table 2.
We examined the possible influence of the reporting of method-
ological characteristics of trials on the observed effect size in strat-
ified analysis of the 15 studies comparing antibiotics with placebo
(Crowley 2001; Darj 1987; Heisterberg 1985a; Heisterberg
1985b; Heisterberg 1987; Heisterberg 1988; Krohn 1981; Krohn
1986; Larsson 1992; Larsson 2000; Levallois 1988; Nielsen 1993;
Sonne-Holm 1981; Sorensen 1992; Westrom 1981). Table 3
summarises these findings. Table 4 shows the results of meta-
regression analysis. In the domains of sequence generation, al-
location concealment and blinding, the effect of antibiotics was
stronger in trials with adequate reporting than in those with in-
adequate reporting. Confidence intervals were, however, wide and
included the possibility of chance findings. The trial with themost
marked effect of the intervention (RR 0.12, 95% CI 0.04 to 0.38)
(Levallois 1988) was amongst those with adequate reporting of
these methodological features.
Figure 3 shows a funnel plot of all 19 trials. There was strong
evidence of small study biases (Egger test P value = 0.002).
Figure 3. Funnel plot: 19 trials included in the main analysis
Effects of interventions
See: Summary of findings for the main comparison Summary
table of secondary outcomes in all 19 trials reviewed
Figure 2 (Analysis 1.1) shows the results of all individual included
trials, according to the particular review objective.
Objective 1: Effectiveness of antibiotic prophylaxis in prevent-
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ing post-abortal pelvic infection
There were 15 trials comparing any antibiotic regimen with
placebo (Figure 4, Analysis 2.1) (Crowley 2001; Darj 1987;
Heisterberg 1985a; Heisterberg 1985b; Heisterberg 1987;
Heisterberg 1988; Krohn 1981; Krohn 1986; Larsson 1992;
Larsson 2000; Levallois 1988; Nielsen 1993; Sonne-Holm 1981;
Sorensen 1992; Westrom 1981). These trials included a total of
7025 women (median 378 patients, range 55 to 1276). Of these,
3525 women were randomised to the intervention arm receiving
antibiotics and 3500 women to the control arm receiving placebo.
A total of 203 patients in the intervention arms compared with
330 in the control arms developed upper genital tract infection,
according to the authors’ definitions.
Figure 4. Effect of antibiotic prophylaxis on post-abortal upper genital tract infection, 15 trials: by reporting
of universal antibiotic prophylaxis.
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Overall effectiveness of antibiotic prophylaxis
The pooled RR for all trials of any antibiotic regimen was 0.59
(95% CI 0.46 to 0.75; 95% PI 0.30 to 1.14) in random-effects
meta-analysis. There was statistical evidence of heterogeneity be-
tween the trial results, with 39% of the variation in results due to
factors other than chance. The results of individual trials ranged
from: an 88% reduction in the incidence of post-abortal upper
genital tract infection inwomen receiving three perioperative doses
of doxycycline on the day of the abortion (3/536) compared with
placebo (26/541) (RR 0.12, 95% CI 0.04 to 0.38) (Levallois
1988), to no effect of a seven day course of lymecycline (25/269
women developed post-abortal upper genital tract infection com-
pared with placebo (25/263) (RR 0.98, 95% CI 0.58 to 1.66)
(Heisterberg 1985a).
We examined potential reasons for heterogeneity in stratified anal-
yses (Table 3). In general, themagnitude of the effects of antibiotic
prophylaxis in all strata was distributed around that of the overall
pooled estimate, ranging from RR 0.5 to 0.7, representing a re-
duction in the risk of post-abortal upper genital tract infection of
approximately 30-50%. Considering characteristics of the inter-
vention and study populations, there was no evidence of between-
trial heterogeneity (I2 = 0%) in RCTs that examined the effec-
tiveness of nitroimidazole antibiotics (six trials) or penicillins (two
trials), in trials using single doses of antibiotics (six trials), or in
RCTs in which ≥ 12% of women in the control group developed
post-abortal upper genital tract infection (eight trials).
Universal antibiotic prophylaxis
No authors of individual trials described the intervention as uni-
versal antibiotic prophylaxis. Of the 15 trials, only one explicitly
stated that women were included without regard to laboratory di-
agnoses ofC. trachomatis orN. gonorrhoeae at baseline (Darj 1987).
Darj 1987 included 800 women randomised to treatment with a
single oral dose of doxycycline or placebo 10-12 hours before the
abortion (Analysis 2.1). Baseline cultures for aerobic and anaero-
bic bacteria were not taken. Amongst women included in analy-
sis, the incidence of post-abortal upper genital tract infection was
2% (8/386) in women receiving doxycycline and 6% (24/383) in
women receiving placebo (RR 0.33, 95% CI 0.15 to 0.73).
In four further trials (Krohn 1981; Krohn 1986; Sonne-Holm
1981; Heisterberg 1985b) it was unclear if a strategy of universal
antibiotic prophylaxis had been followed or not, because exclusion
criteria were not explicitly stated (Krohn 1981; Krohn 1986;
Sonne-Holm 1981; Heisterberg 1985b), or preoperative tests for
infection were not mentioned (Sonne-Holm 1981). In these four
trials the pooled RR was 0.49 (95% CI 0.32 to 0.75, I2 = 0%,
fixed-effect model).
In all the remaining trials, authors stated that women with labora-
tory diagnoses of genital infections would be excluded or treated
preoperatively (Crowley 2001; Heisterberg 1985a; Heisterberg
1987; Heisterberg 1988; Larsson 1992; Larsson 2000; Levallois
1988; Nielsen 1993; Sorensen 1992; Westrom 1981). There was
moderate between-trial heterogeneity (I2 = 43%) with a pooled
RR 0.67 (95% CI 0.56 to 0.81, 95% PI 0.32 to 1.36, random-
effects model).
Antibiotic class
Figure 5 shows the results of trials according to the class of antibi-
otic used (Analysis 3.1). Six RCTs compared the effect of nitroim-
idazoles to placebo and found strong evidence of a prophylactic ef-
fect with no evidence of between-trial heterogeneity (I2 = 0%, RR
0.51, 95% CI 0.35 to 0.73, fixed-effect model) (Crowley 2001;
Heisterberg 1985b;Heisterberg 1987; Krohn1981; Larsson 1992;
Westrom 1981). All but one of these trials (Krohn 1981) excluded
or treated women with gonorrhoea at baseline and two trials ex-
cluded or treated women with chlamydia at baseline (Crowley
2001; Larsson 1992).
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Figure 5. Effect of antibiotic prophylaxis on post-abortal upper genital tract infection, 15 trials: by antibiotic
class
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Four trials used tetracyclines. There was evidence of severe het-
erogeneity between trial results (I2 = 78%) and the pooled results
were not used (Darj 1987; Heisterberg 1985a; Heisterberg 1988;
Levallois 1988). All but one trial (Darj 1987) excluded women
with gonorrhoea at baseline. This group included the two tri-
als with the weakest (Heisterberg 1985a) and strongest (Levallois
1988) effects of the interventions. Heisterberg 1985a analysed re-
sults from 532 women (118 excluded post randomisation), in-
cluding 10 (1.9%) with chlamydia. The incidence of post-abortal
upper genital tract infection was similar in the group receiving 7
days of lymecycline compared with placebo (RR 0.98, 95% CI
0.58 to 1.66). Chlamydia infection was strongly associated with
post-abortal infection (10/48 women with chlamydia vs. 40/481
women without chlamydia, RR 2.5, 95%CI 1.34 to 4.69) but this
trial had the lowest percentage of women infected with chlamy-
dia. No testing for bacterial vaginosis was reported. Levallois 1988
analysed 1077 women (23 excluded post randomisation), includ-
ing 75 (7.0%) with chlamydia. No testing for bacterial vaginosis
was reported. Two phases of the trial were reported: in phase 1,
women were enrolled, irrespective of chlamydia test results (N =
75); in phase 2, only women with negative chlamydia tests were
enrolled (N = 1002). The overall RR was 0.12 (95% CI 0.04 to
0.38).
Only two studies compared beta lactam antibiotics to placebo and
the results of these trials demonstrated a consistent decrease in
post-abortal infection (pooled RR 0.52, 95% CI 0.31 to 0.88, I
2 = 0%, fixed-effect model) (Krohn 1986; Sonne-Holm 1981).
Women with gonorrhoea were excluded by Sonne-Holm et al. but
not Krohn.
Fluoroquinolones (Nielsen 1993), macrolides (Sorensen 1992)
and glycosides (Larsson 2000) were examined in only one trial
each (Figure 5).
Route of administration
Antibiotics were given orally in 12 of the 15 trials with moderate
between-trial heterogeneity (pooled RR 0.54, 95% PI 0.24 to
1.24, random-effect model, I2 = 47%) (Darj 1987; Heisterberg
1985a; Heisterberg 1985b; Heisterberg 1987; Heisterberg 1988;
Krohn 1981; Larsson 1992; Nielsen 1993; Sonne-Holm 1981;
Sorensen 1992; Westrom 1981) (Analysis 4.1, Figure 6). One trial
each examined intravenous (Krohn 1986), intravaginal (Larsson
2000) and rectal (Crowley 2001) routes of administration.
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Figure 6. Effect of antibiotic prophylaxis on post-abortal upper genital tract infection, 15 trials: by route of
antibiotic administration
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Timing and frequency of antibiotic administration
Figure 7 (Analysis 5.1) shows trial results stratified by the tim-
ing of antibiotic administration. There was between-trial hetero-
geneity in all strata. Four trials gave antibiotics preoperatively (RR
0.61, 95% PI 0.12 to 3.11, random-effects model, I2 = 39%)
(Darj 1987; Krohn 1981; Larsson 2000;Westrom 1981). Six trials
used perioperative administration (RR 0.48, 95% PI 0.10 to 2.33,
random-effects model, I2 = 62%) (Crowley 2001; Heisterberg
1985b; Heisterberg 1987; Krohn 1986; Levallois 1988; Nielsen
1993); four studies gave antibiotics pre- and postoperatively (RR
0.67, 95% PI 0.16 to 2.89, random-effects model, I2 = 29%)
(Heisterberg 1985a; Heisterberg 1988; Larsson 2000; Sorensen
1992) and in one study antibiotics were given peri- and postoper-
atively (Sonne-Holm 1981).
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Figure 7. Effect of antibiotic prophylaxis on post-abortal upper genital tract infection, 15 trials: by timing of
antibiotic administration
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Figure 8 shows trial results stratified by the frequency of the an-
tibiotic regimen (Analysis 6.1). Six studies used a single oral dose
of antibiotics, with little between-trial heterogeneity in results
(RR 0.63, 95% CI 0.50 to 0.80, fixed-effect model, I2 = 0%)
(Crowley 2001; Darj 1987; Krohn 1981; Krohn 1986; Nielsen
1993; Westrom 1981). The results of six trials using multiple
doses of antibiotics given over several days were also reasonably
consistent (RR 0.71, 95% CI 0.55 to 0.92, fixed-effect model, I
2 = 22%) (Heisterberg 1985a; Heisterberg 1988; Larsson 1992;
Larsson 2000; Sonne-Holm 1981; Sorensen 1992). Trials that in-
volved the use of multiple doses of antibiotic on the same day
were very heterogeneous (I2 = 73%, 3 trials) (Heisterberg 1985b;
Heisterberg 1987; Levallois 1988). There were no trials directly
comparing different antibiotics as well as different routes and fre-
quency of antibiotic administration.
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Figure 8. Effect of antibiotic prophylaxis on post-abortal upper genital tract infection, 15 trials: by antibiotic
dosing schedule
Current or past upper genital tract infection
Seven studies reported the number of women with a history of
PID (Figure 9, Analysis 7.1) (Darj 1987; Heisterberg 1985b;
Heisterberg 1987; Heisterberg 1988; Nielsen 1993; Sonne-Holm
1981; Sorensen 1992). Figure 9 shows results from the five studies
that compared the development of post-abortal upper genital tract
infection according to the presence or absence of previous PID.
Two trials that involved only women with previous PID are not
included (Heisterberg 1987; Heisterberg 1988). The magnitude
of the effect of prophylactic antibiotics was similar in women with
(RR 0.55, 95% Cl 0.32 to 0.96, fixed-effect meta-analysis, I2 =
27%) with and without a history of PID (RR 0.66, 95% CI 0.45
to 0.96, random-effects meta-analysis, I2 = 25%).
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Figure 9. Effect of antibiotic prophylaxis on post-abortal upper genital tract infection in women with a
history of PID, 5 trials
Seven studies reported data on chlamydia testing before abortion
(Crowley 2001; Heisterberg 1985a; Krohn 1986; Larsson 1992;
Larsson 2000; Levallois 1988; Sorensen 1992); two did not test
all participants (Heisterberg 1985a; Krohn 1986). Two other tri-
als excluded all chlamydia positive women from participating in
the trial (Larsson 1992; Larsson 2000) and Crowley et al. treated
all women with chlamydia preoperatively. Two studies were in-
cluded in a stratified analysis, according to baseline chlamydia sta-
tus (Levallois 1988; Sorensen 1992) (Figure 10). In women with
chlamydia at baseline, both trials showed evidence that prophy-
lactic antibiotics (doxycycline or erythromycin) reduced the in-
cidence of post-abortal upper genital tract infection (pooled RR
0.14, 95% CI 0.03 to 0.57, fixed-effect meta-analysis, I2 = 0%)
(Figure 10; Analysis 8.1). In women without chlamydia at baseline
the two trials showed contrasting effects and data were not pooled
(I2 = 81%).
21Perioperative antibiotics to prevent infection after first-trimester abortion (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 10. Effect of antibiotic prophylaxis on post-abortal upper genital tract infection in women with
chlamydia at baseline, 2 trials
All eleven studies testing their participants for gonorrhea excluded
women who were found positive (Crowley 2001; Heisterberg
1985a; Heisterberg 1985b; Heisterberg 1987; Heisterberg 1988;
Heisterberg 1986; Larsson 1992; Larsson 2000; Levallois 1988;
Nielsen 1993; Sorensen 1992). Two trials who tested for bacterial
vaginosis included only women with positive testing (Crowley
2001; Krohn 1986).
When the trials were stratified according to the level of upper geni-
tal tract infection diagnosed in the control group (Table 3), results
were heterogeneous in those with levels below the median for all
trials (I2 = 63%) (Darj 1987; Heisterberg 1985a; Krohn 1981;
Krohn 1986; Larsson 2000; Sonne-Holm 1981). Amongst trials
in women with a high risk of upper genital tract infection the re-
sults were more consistent (pooled RR 0.64, 95%CI 0.51 to 0.80,
fixed-effect model, I2 = 0%) (Crowley 2001; Heisterberg 1985b;
Heisterberg 1987;Heisterberg 1988; Larsson 1992; Nielsen 1993;
Sorensen 1992; Westrom 1981).
Objective 2. To determine themost effective antibiotic regimen
for preventing post-abortal upper genital tract infection
Three trials compareddifferent types of antibiotic regimen:Caruso
2008 and Lichtenberg 2003 compared different durations of the
same antibiotic (prulifloxacin and doxycycline, respectively) and
Heisterberg 1986 compared two different antibiotics with the
same regimen for both. None of the trials was stated to be a non-
inferiority trial. In the trials by Heisterberg 1986 and Lichtenberg
2003, there was no statistical evidence of a difference in the inci-
dence of post-abortal upper genital tract infection between groups.
Caruso 2008 found that a five day regimen of prulifloxacin start-
ing after the abortion resulted in a higher incidence of post-abortal
upper genital tract infection compared with a three day regimen
starting the day before the abortion (RR 4.13, 95% CI 1.41 to
12.08). No study compared different antibiotic combinations to
a single antibiotic or to another combination of antibiotics.
Objective 3. To determine the most effective strategy for pre-
venting post-abortal upper genital tract infection by compar-
ing universal antibiotic prophylaxis with a screen-and-treat
strategy, or with a combination of screen-and-treat plus uni-
versal prophylaxis
One trial compared the effectiveness of a screen-and-treat strat-
egy with universal prophylaxis (Penney 1998). In the screen-and-
treat arm, women were tested preoperatively for chlamydia, gon-
orrhoea and bacterial vaginosis; those with positive results re-
ceived appropriate antibiotics for the infection(s) diagnosed (doxy-
cycline, ciprofloxacin and metronidazole, respectively) and were
referred to a genitourinary medicine clinic for partner notifica-
tion. Women with negative screening tests did not receive any
antibiotics. Women allocated to universal antibiotic prophylaxis
received a single dose of 1 g metronidazole rectally on the day of
the abortion followed by doxycycline 100 mg twice daily orally for
seven days. A total of 1672 women was randomised but, owing to
limited resources, this did not reach the planned number, accord-
ing to the sample size calculation. The incidence of post-abortal
upper genital tract infection was higher in women allocated to the
screen-and-treat strategy compared to universal prophylaxis (RR
1.53, 95% CI 0.99 to 2.36) (Penney 1998). Of 45 women in the
screen-and-treat group referred to a genitourinary medicine clinic,
22Perioperative antibiotics to prevent infection after first-trimester abortion (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
only 11 attended and only 4 out of 10 partners identified by these
women were known to have attended the clinic for treatment.
D I S C U S S I O N
Summary of main results
This systematic review included 19RCTs that examined the effects
of perioperative antibiotics to prevent post-abortal upper genital
tract infection in women undergoing surgical abortion. In 15 of
the 19 trials an antibiotic regimen was compared with placebo and
demonstrated a decrease in post-abortal infection; however, only
one of these trials appeared to use universal antibiotic prophylaxis
without excluding women with genital infections at baseline (RR
0.33, 95% CI 0.15 to 0.73). In four trials where it was unclear
whether universal prophylaxis was used, the pooled RR was 0.49
(95% CI 0.32 to 0.75, I2 = 0%, fixed-effect model). In 10 trials
that excluded women with infections the protective effect of an-
tibiotics was less pronounced and there was moderate between-
trial heterogeneity (pooled RR 0.65, 95% CI 0.32 to 1.36, ran-
dom-effects model, I2 = 43%).
There were too few trials that compared different antibiotic reg-
imens to determine the most effective regimen. No trials com-
pared different antibiotic combinations to a single antibiotic or
to another combination of antibiotics. It was not possible to de-
termine whether a screen-and-treat strategy compared to univer-
sal antibiotic prophylaxis was more effective in preventing post-
abortal upper genital tract infection as only one trial made this
comparison (RR 1.53, 95% CI 0.99 to 2.36). This was the only
trial in which partner notification for women with chlamydia or
gonorrhoea was carried out; of 91 women with chlamydia, only
4 of 10 notified partners were known to have attended the same
genitourinary medicine clinic for treatment.
We did not identify any RCTs examining the effect of antibiotic
prophylaxis in women having medical abortion. None of the in-
cluded RCTs was conducted in a low or middle income country.
Strengths and weaknesses
The main strengths of this review were that we considered differ-
ent strategies for preventing post-abortal upper genital tract infec-
tion. We examined separately the strategies of universal antibiotic
prophylaxis, in which antibiotics are given without taking tests
for infections preoperatively and antibiotic prophylaxis in which
women with specific infections were excluded or treated preoper-
atively. In this review, there were many differences between study
populations, interventions, inclusion and exclusion criteria and
diagnostic criteria so real heterogeneity was expected. We tried to
take this into account in the presentation of results when there was
evidence of moderate or severe heterogeneity (I2 > 25%), using a
strategy suggested by Riley and colleagues (Riley 2011). In these
situations we presented 95% CI and a 95% PI, which describe the
uncertainty around the intervention effect estimated in random-
effects models. The estimate from the random-effects model is
the average effect across the trials. Its CI expresses the statistical
uncertainty around the average effect, not the potential effect in
an individual population or setting, which may differ from the
average. The PI reflects the range of effects across the different
settings in which the trials were conducted (Riley 2011).
A weakness of the review is the statistical evidence of publication
or other small study biases in the 15 trials included in this review.
This suggests that there might be trials with results showing no
effect or a harmful effect of antibiotic prophylaxis in women pre-
senting for first-trimester surgical abortion. The effect estimated
in this review might, therefore, overestimate the prophylactic ef-
fect. Limitations of included studies include differences in the di-
agnostic criteria for both baseline infections (particularly bacte-
rial vaginosis) and for the primary outcome of post-abortal upper
genital tract infection (there are no agreed criteria), and duration
of follow-up for diagnosing the primary outcome (two to eight
weeks).
Comparison with other studies
This review updates and adds to information in the previous sys-
tematic review of antibiotic prophylaxis to prevent post-abortal
upper genital tract infection, published by Sawaya 1996 and col-
leagues. The 12 trials studied by Sawaya 1996 were all identified in
our searches and included in our review. Since our search strategy
included more databases than that of Sawaya and colleagues, it is
unlikely that we missed published trials. In addition to placebo
controlled trials we also included trials comparing different an-
tibiotic regimens and different prophylaxis strategies. Therefore,
we included the only trial to compare the screen-and-treat strategy
with universal antibiotic prophylaxis (Penney 1998). Sawaya 1996
concluded that there has been strong evidence that antibiotics re-
duce the risk of post-abortal infection in all groups of women.
This conclusion was based on a meta-analysis that used a fixed-
effect model to estimate a pooled common RR of 0.58 (95% CI
0.47 to 0.71), despite marked between-trial heterogeneity. In this
review, we quantify and explore the heterogeneous results between
trials.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
A general strategy of perioperative antibiotics at the time of first-
trimester surgical abortion is effective in preventing post-abortal
upper genital tract infection, with an average reduction of 41%
(95% CI 25 to 54%, random-effects model). The level of between
trial heterogeneity suggests that this effect might not, however,
apply to all settings, population groups or interventions. To take
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this into account, we also estimated a 95% PI, which is wider than
the 95% CI (RR 0.59, 95% PI 0.30 to 1.14).
There are sub-groups amongst whom antibiotic prophylaxis had a
beneficial effect, with no evidence of between trial heterogeneity:
women receiving nitroimidazole antibiotics and single dose regi-
mens; and settings in which the rate of post-abortal upper genital
tract infection was 12% or more. In this review, there was a ben-
eficial effect both in women with and without a history of PID.
The majority of trials included in the review did not evaluate a
strategy of universal antibiotic prophylaxis as it would be applied
in practice, i.e. giving prophylaxis to all women without doing
tests to screen for existing gonorrhoea and chlamydia. This is be-
cause many trials had planned or actual exclusions (or treatment)
of women who had infections diagnosed preoperatively. The pro-
phylactic effect of antibiotics was actually weakest in the group
of trials that did not use universal prophylaxis, perhaps because
the opportunity to prevent post-abortal infections was reduced by
the exclusion of those with infections. The antibiotic prophylac-
tic regimen selected in practice should take into account the local
epidemiology of lower genital tract infection.
This review did not determine the most effective antibiotic regi-
men because there were too few trials making such comparisons.
In stratified analyses of placebo controlled trials nitroimidazoles
prevented post-abortal upper genital tract infections with no evi-
dence of between trial heterogeneity. Anaerobes or organisms asso-
ciated with bacterial vaginosis might, therefore, be important ae-
tiologically. In addition, two trials showed an effect of antibiotics
active against chlamydia in women who were infected with C. tra-
chomatis at baseline. Only one included trial used a combination
of antibiotics; Penney 1998 gave metronidazole and doxycycline.
This antibiotic combination has been recommended in guidelines
as it covers bacterial vaginosis andC. trachomatis. In a trial that was
not included in the review because only half the women were in
the first trimester,Miller 2004 compared a combination of a seven
day course of metronidazole and doxycycline with doxycycline
alone in women with bacterial vaginosis. They found that the ad-
dition of metronidazole did not reduce the incidence of post-abor-
tal infectious complications, defined using a symptom score. Sin-
gle dose regimens also appeared to be associated with a consistent
reduction in the risk of post-abortal upper genital tract infection.
Of note, four of these trials assessed the outcome at two weeks or
sooner (Krohn 1981; Krohn 1986; Nielsen 1993; Westrom 1981)
and three of the trials used nitroimidazoles, which also showed a
consistent effect (Crowley 2001; Krohn 1981; Westrom 1981).
The findings of this review are consistent with existing guidelines
on antibiotic prophylaxis. In the USA, the American College of
Obstetrics and Gynecology (ACOG 2006) did not recommend
any particular regimen,whilst the Society of Family Planning states
that both nitroimidazoles and tetracyclines are effective (Achilles
2011). Guidance about the duration of the prophylactic regimen
differs. The US Society of Family Planning recommends that an-
tibiotics should not be given for more than three days (Achilles
2011). In the UK, Royal College of Obstetrics and Gynaecology
guidelines recommend single dose metronidazole with single dose
azithromycin or a seven day course of doxycycline (RCOG 2011).
The Scottish Intercollegiate Guidelines Network has published
general guidelines about antibiotic prophylaxis for surgical proce-
dures and notes that in ’several studies... longer dose duration has
no increased benefit’ but no specific evidence about abortion was
identified (SIGN 2008).
The implications of lower genital tract infections that are sexu-
ally transmitted or sexually transmissible for women and their sex
partner(s) should be taken into consideration when developing
strategies for the prevention of post-abortal upper genital tract in-
fection. If pre-abortion screening tests for infection are not done,
practitioners should give women information about the specific
infections not covered by the prophylactic regimen, so that they
can seek diagnosis, treatment and partner services. If pre-abortion
infection screening tests are done, practitioners should provide full
treatment and follow-up care for women diagnosed with a sexu-
ally transmitted infection. The single trial by Penney 1998 did not
determine whether or not there is a difference in the effectiveness
of screen-and-treat and universal antibiotic prophylaxis strategies.
There were fewer episodes of post-abortal upper genital tract in-
fection in women receiving universal antibiotic prophylaxis, but
95% CI were wide. Furthermore, the authors of the trial tried
to ensure treatment for partners to prevent re-infection but very
few were known to have attended a clinic for treatment. The im-
plications of this for re-infection are not known; the low partner
notification success rate could reflect an inability to reach partners
in partnerships that had ended, or a failure to reach ongoing sex
partners.
The results of the review cannot be generalised to women having
medical abortions because we did not find any relevant trials.
The results of the review cannot be generalised to women in the
second trimester of pregnancy because the protocol specified only
first-trimester abortion. Future updates should include second-
trimester abortion.
Since all included trials were conducted in high income countries
where testing is available, the results cannot necessarily be gen-
eralised to low and middle income countries, where the preva-
lence of sexually transmitted and endogenous infections in women
requesting abortion might well differ and where screening tests
might not be available.
Implications for research
Further RCTs comparing prophylactic regimens of different an-
tibiotics with each other or combinations of antibiotics with a sin-
gle antibiotic would be useful. Such trials could be done in low
and middle income countries and settings in which the prevalence
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of lower genital tract infections in women presenting for abortion
is high.
Observational cohort studies of women who have had abortions
could give valuable information about the risk of re-infection and
of upper genital tract damage as longer term consequences of abor-
tion. Follow- up of RCTs could include a time period that is long
enough to investigate the incidence of re-infection and the out-
comes of partner notification, where appropriate, in women who
have received antibiotic prophylaxis.
Further research to improve the accuracy and reproducibility of
diagnostic criteria for upper genital tract infection would help to
improve objective diagnosis.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Caruso 2008
Methods - Single centre, Italy
- Study period September 2005 - March 2007
- Follow-up period 4 weeks
Participants - Number of women randomised unclear, 466 women analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria not reported
- Preoperative infections: not tested for
Interventions Antibiotic prophylaxis compared with alternative regimens of the same antibiotic
- Intervention, arm 1: prulifloxacin 600 mg once daily, oral (postoperative, 5 days)
- Intervention, arm 2: prulifloxacin 600 mg once daily, oral (postoperative, 3 days)
- Intervention, arm 3: prulifloxacin 600 mg once daily, oral (peri-operative 3 doses, 1 dose preoperatively, 2 doses
postoperative)
Outcomes PID diagnosis defined as all of the following: pelvic pain, fever, vaginal discharge
Notes Unclear if intervention is universal antibiotic prophylaxis according to protocol definition. Number of potentially
eligible women excluded and reasons for exclusion not reported. Included in descriptive analysis only because com-
parison groups also received antibiotics
Crowley 2001
Methods - Multicentre (3 hospitals), England (Bristol, Taunton)
- Study period October 1996 - December 1998
- Follow-up period 4 weeks
Participants - 273 women randomised, 273 analysed
- Women presenting for surgical abortion in first trimester who had bacterial vaginosis
- Exclusion criteria: result of bacterial vaginosis test received after surgery
- Preoperative infections:
1) History of PID: arm 1: 9/142, arm 2: 5/131
2) Chlamydia: arm 1: 10/142, arm 2: 11/131, all treated preoperatively
3) Gonorrhoea: none (tested in 2/3 hospitals)
4) Bacterial vaginosis: all women
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: metronidazole 2 g single dose, rectal (peri-operative during oper-
ation)
- Control arm, 2: placebo
Outcomes 1) Upper genital tract infection within 4 weeks, defined as: prescription for antibiotics
by general practitioner for at least 2 of the following symptoms:
- Fever; lower abdominal pain; heavy vaginal bleeding; offensive or bloody vaginal dis-
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Crowley 2001 (Continued)
charge; OR readmission to hospital with a clinical diagnosis of PID
2) Readmission to hospital
Notes Not universal antibiotic prophylaxis according to protocol definition; all women screened
for chlamydia and those with positive test results treated preoperatively
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Allocation concealment (selection bias) Low risk
Incomplete outcome data (attrition bias) Low risk
Darj 1987
Methods - Single centre, Sweden (Falun)
- Study period 18 months, dates not specified
- Follow-up visit after 4 weeks
Participants - 800 women randomised, 769 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: clinical signs of genital infection; antibiotic treatment within 3weeks
of procedure; allergy to treatment
- Preoperative infections:
1) History of PID: arm 1: 80/386, arm 2: 84/383
2) Chlamydia: not reported (not tested)
3) Gonorrhoea: not reported (not tested)
4) Bacterial vaginosis: not reported (not tested)
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: doxycycline 400 mg, single dose, oral (preoperative, 12h before)
- Control, arm 2: placebo
Outcomes 1) PIDdefined as lower abdominal pain plus at least 2 of the following: abnormal purulent
discharge; temperature > 38 °C; palpable adnexal mass; erythrocyte sedimentation rate
> 15 mm/hour; heavy or prolonged bleeding;
2) Adverse effect of antibiotic prophylaxis
Notes Universal antibiotic prophylaxis
Risk of bias
Bias Authors’ judgement Support for judgement
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Darj 1987 (Continued)
Random sequence generation (selection
bias)
Low risk
Allocation concealment (selection bias) Low risk
Incomplete outcome data (attrition bias) Low risk
Heisterberg 1985a
Methods - Single centre, Denmark (Copenhagen)
- Study period: not reported
- Follow-up visit after 2 weeks
Participants - 650 women randomised, 532 analysed
- Women presenting for surgical abortion in the first trimester
- Exclusion criteria: allergy to treatment; antibiotic treatment at the time of abortion; active
haematological or neurological disease; alcohol abuse; positive test for N. gonorrhoeae
- Infections preoperatively:
1) History of PID: not reported in detail
2) Chlamydia: arm 1: 29/269 , arm 2: 19/260 (culture not obtained in 3 women)
3) Gonorrhoea: all women tested, 6 women with positive result excluded
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: lymecycline 300 mg twice daily, oral (pre- and postoperative,
starting 2 days before, total 7 days)
- Control, arm 2: placebo
Outcomes 1) Post-abortal genital infection defined as:
a) Patient seen at follow-up visit after 2 weeks, at least 3 of the following: temperature >
38 °C; continued pelvic pain; malaise with tender adnexal mass; pathologic discharge or
bleeding
b) Patient admitted before scheduled follow-up, at least 2 of the following: temperature
> 38 °C; moderate tenderness of the uterus; tender adnexal mass; pathologic discharge or
bleeding; OR
c) Patient not seen at the follow-up visit, at least 4 of the following: temperature > 38 °C
for > 24h; pelvic pain > 5 days; bleeding more than normal menstrual flow for >5 days;
foul discharge; infection diagnosed by physician
2) Adverse effects of antibiotics
Notes Not universal antibiotic prophylaxis according to protocol definition; study population
included only women without gonorrhoea at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
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Heisterberg 1985a (Continued)
Incomplete outcome data (attrition bias) Low risk
Heisterberg 1985b
Methods - Single centre, Denmark (Copenhagen)
- Study period March 1982 - August 1982
- Follow-up visit after 2 weeks
Participants - 119 women randomised, 100 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: allergy to treatment; treatment with antibiotics at the time of abor-
tion; active haematological or neurological disease; alcohol abuse or treatment with disul-
firam (Antabuse); positive test for N. gonorrhoeae
- Preoperative infections:
1) History of PID: arm 1: 13/ 51, arm 2: 12/49
2) Chlamydia: not reported
3) Gonorrhoea: all tested, none positive
4) Bacterial vaginosis: not reported (culture forGardnerella vaginalis, results not reported
by group)
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: metronidazole 400 mg, oral (peri-operative 3 doses, 1h before, 4h
after, 8h after abortion)
- Control, arm 2: placebo
Outcomes 1) Post-abortal PID defined as:
a) Patient seen at follow-up visit after 2 weeks, at least 3 of the following: temperature
> 38 °C; continued pelvic pain; malaise with tender adnexal mass; pathologic discharge
or bleeding
b) Patient admitted before scheduled follow-up, at least 2 of the following: temperature
> 38 °C; moderate tenderness of the uterus; tender adnexal mass; pathologic discharge
or bleeding
Notes Not universal antibiotic prophylaxis according to protocol definition; study population
included only women without gonorrhoea at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Incomplete outcome data (attrition bias) Low risk
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Heisterberg 1986
Methods - Single centre, Denmark (Copenhagen)
- Study period not reported
- Follow-up visit after 2 weeks
Participants - 102 women randomised, 81 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: allergy to treatment; treatment with antibiotics at the time of abor-
tion; active haematological or neurological disease; alcohol abuse or treatment with disul-
firam (Antabuse); positive test for N. gonorrhoeae
- Preoperative infections:
1) History of PID: all women, 43/43 in arm 1 and 38/38 in arm 2
2) Chlamydia: not reported
3) Gonorrhoea: all tested, none positive
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared with alternative regimens of the same antibiotic
- Intervention, arm 1: metronidazole 400 mg, oral (peri-operative 3 doses, 1h before, 4h
after and 8h after abortion)
- Control, arm 2: pivampicillin 350 mg, oral (peri-operative 3 doses, 1h before, 4h after
and 8h after abortion)
Outcomes 1) Post-abortal PID defined as:
a) Patient seen at follow-up visit after 2 weeks, at least 3 of the following: temperature
> 38 °C; continued pelvic pain; malaise with tender adnexal mass; pathologic discharge
or bleeding
b) Patient admitted before scheduled follow-up, at least 2 of the following: temperature
> 38 °C; moderate tenderness of the uterus; tender adnexal mass; pathologic discharge
or bleeding
2) Re-admission to hospital
Notes Not universal antibiotic prophylaxis according to protocol definition; study population
included only women without gonorrhoea at baseline. All had a history of PID
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Incomplete outcome data (attrition bias) Low risk
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Heisterberg 1987
Methods - Single centre, Denmark (Copenhagen)
- Study period February 1983 - November 1983
- Follow-up visit after 2 weeks
Participants - 135 women randomized, 118 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: allergy to treatment; treatment with antibiotics at the time of abor-
tion; active haematological or neurological disease; alcohol abuse or treatment with disul-
firam (Antabuse); positive test for N. gonorrhoeae
- Preoperative infections:
1) History of PID: all women, 64/64 in arm 1, 54/54 in arm 2
2) Chlamydia: not reported
3) Gonorrhoea: all women tested, 2 women with positive test excluded
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: metronidazole 400 mg, oral (peri-operative 3 doses, 1h before, 4h
after, 8h after abortion)
- Control, arm 2: placebo
Outcomes 1) Post-abortal PID defined as:
a) Patient seen at follow-up visit after 2 weeks, at least 3 of the following: temperature
> 38 °C; continued pelvic pain; malaise with tender adnexal mass; pathologic discharge
or bleeding
b) Patient admitted before scheduled follow-up, at least 2 of the following: temperature
> 38 °C; moderate tenderness of the uterus; tender adnexal mass; pathologic discharge
or bleeding
2) Readmission to hospital
Notes Not universal antibiotic prophylaxis according to protocol definition; study population
included only women without gonorrhoea at baseline. All had a history of PID
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Incomplete outcome data (attrition bias) Low risk
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Heisterberg 1988
Methods - Single centre, Denmark (Copenhagen)
- Study period not reported
- Follow-up visit after 2 weeks
Participants - 90 women randomised, 55 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: allergy to treatment; antibiotic treatment at the time of abortion;
active haematological or neurological disease; alcohol abuse; positive test for N. gonor-
rhoeae
- Preoperative infections:
1) History of PID: all women, 24/24 in arm 1, 31/31 in arm 2
2) Chlamydia: arm 1: 2/24, arm 2: 1/31
3) Gonorrhoea: not reported but all women tested and if positive excluded
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: lymecycline 300 mg once daily, oral (pre- and postoperative,
starting on the morning of the operation, total 14 days)
- Control, arm 2: placebo
Outcomes 1) Post-abortal infection defined as:
a) Patient seen at follow-up visit after 2 weeks, at least 3 of the following: temperature
> 38 °C; continued pelvic pain; malaise with tender adnexal mass; pathologic discharge
or bleeding
b) Patient admitted before scheduled follow-up, at least 2 of the following: temperature
> 38 °C; moderate tenderness of the uterus; tender adnexal mass; pathologic discharge
or bleeding; OR
c) Patient not seen at the follow-up visit, at least 4 of the following: temperature > 38
°C for > 24h; pelvic pain > 5 days; bleeding more than normal menstrual flow for > 5
days; foul discharge; infection diagnosed by physician
2) Readmission to hospital
Notes Not universal antibiotic prophylaxis according to protocol definition; study population
included only women without gonorrhoea at baseline. All had a history of PID
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Incomplete outcome data (attrition bias) Low risk
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Krohn 1981
Methods - Single centre, Sweden (Norrkoping)
- Study period not reported
- Follow-up visit after 8-10days
Participants - 210 women randomised, 210 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: known genitourinary disease (not specified if infections included);
antibiotic treatment at time of abortion;
- Pre-opertative infections:
1) History of PID: not reported
2) Chlamydia: not reported
3) Gonorrhoea: not reported
4) Bacterial vaginosis: not reported, anaerobes cultured
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: tinidazole 2 g, oral (preoperative single dose, number of hours/
days before abortion not stated)
- Control, arm 2: Placebo
Outcomes 1) Pelvic infection (endometritis or salpingitis): endometritis defined as temperature > 38
°C; soft and tender uterus and brick-red discharge from cervix; salpingitis, no definition
given
2) Readmission to hospital
Notes Unclear if intervention was universal antibiotic prophylaxis according to protocol defini-
tion; study population did not exclude women with infections at baseline but excluded
women on antibiotics at the time of the abortion. Outcomes poorly defined
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Krohn 1986
Methods - Single centre, Sweden (Norrkoping)
- Study period not reported
- Follow-up visit after 1 and 2 weeks
Participants - 305 women randomised, 285 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: not reported
- Preoperative infections:
1) History of PID: not reported
2) Chlamydia: 100 of 285 women tested, 8 positive (all in arm 1)
3) Gonorrhoea: all women tested, none infected
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Krohn 1986 (Continued)
4) Bacterial vaginosis: not reported, anaerobes cultured
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: sulbactam 0.5 g intravenous + ampicillin 1 g intravenous (peri-
operative single dose at time of induction)
- Control, arm 2: placebo
Outcomes 1) Endometritis defined as: temperature > 38 °C on 2 consecutive days; tender uterus;
severe pain or cramps; excessive blood loss; foul vaginal discharge
2) Adverse effects of antibiotics administered
Notes Unclear if universal antibiotic prophylaxis according to protocol definition; no exclusion
criteria reported but women with chlamydia at baseline were not excluded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Incomplete outcome data (attrition bias) High risk
Larsson 1992
Methods - Multicentre (3 hospitals), Sweden (Gothenburg, Skovde, Gavle)
- Study period not reported
- Follow-up visit after 4 weeks
Participants - 231 women randomised, 174 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: antibiotic treatment before operation; repeat curettage; positive C.
trachomatis result
- Preoperative infections:
1) History of PID: not reported
2) Chlamydia: all women tested, 23 women with positive results excluded
3) Gonorrhoea: unclear how many tested, of those tested all negative
4) Bacterial vaginosis: all women, 84/84 in arm 1, 90/90 in arm 2
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: metronidazole 500 mg 3 times daily, oral (pre-and postoperative,
starting up to 1 week before, total 10 days)
- Control, arm 2: placebo
Outcomes Post-abortal PID defined as at least 2 of the following: temperature > 38 °C for > 24h;
continuous abnormal or purulent vaginal discharge after 1 week; continuous abnormal
bleeding after 3 days; palpable adnexal mass; tenderness of uterus or adnexae; erythrocyte
sedimentation rate > 30 mm/h
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Larsson 1992 (Continued)
Notes Not universal antibiotic prophylaxis according to protocol definition; study population
included only women without chlamydia at baseline. All had bacterial vaginosis
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias) High risk
Larsson 2000
Methods - Multicentre (7 hospitals), Sweden and Norway
- Study period May 1994 - October 1995
- Follow-up visit after 4 weeks
Participants - 1655 women randomised, 1276 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: allergy to treatment; history of colitis; current PID; current infection
with trichomonas, gonorrhoea, chlamydia, candida
- Preoperative infections
1) History of PID: not reported
2) Chlamydia: all women tested, 31 with positive results excluded
3) Gonorrhoea: all women tested, unclear how many positive but all excluded
4) Bacterial vaginosis: 220/1095 women tested
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: clindamycin cream 2%, intravaginal (preoperative 5 ml applicator
for 4-7 days before abortion)
- Control, arm 2: placebo
Outcomes Post-abortal infection defined as uterine or adnexal tenderness and at least 1 of the
following: temperature > 38 °C for > 24h; abnormal bleeding after 3 days; abnormal
discharge after 1 week; palpable adnexal mass
Notes Not universal antibiotic prophylaxis according to protocol definition; study population
included only women without chlamydia, gonorrhoea or trichomonas at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Incomplete outcome data (attrition bias) High risk
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Levallois 1988
Methods - Single centre, Canada (Quebec)
- Study periodNovember 1985 -December 1986, split as two phases; phase 1 November
1985 - June 1986, phase 2 July 1986 - December 1986
- Follow-up visit at 4-5 weeks
Participants - 1100 women randomised, analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria before randomisation: allergy to tetracycline; cardiac disease; antibi-
otic therapy at time of abortion; positive test for N. gonorrhoeae; positive test for C.
trachomatis during second half of trial;
Preoperative infections
2) History of PID: not reported
3) Chlamydia: arm 1: 33/536, arm 2: 42/541
4) Gonorrhoea: all tested and if positive excluded
5) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: doxycycline 100 mg 3 doses, oral (peri-operative, x 1 1h before,
x 2 30 min after abortion)
- Control, arm 2: placebo
Outcomes 1) Post-abortal pelvic infection defined as: low abdominal pain; uterine, adnexal or mo-
tion tenderness; purulent leukorrhoea or temperature > 38 °C or erythrocyte sedimen-
tation rate > 15 mm/h or leukocytosis > 10,000/cubic mm; post-abortal severity score >
10 (’composite score of clinical and biological data’, criteria unclear)
2) Side effects of antibiotic prophylaxis
Notes Not universal antibiotic prophylaxis according to protocol definition; study population
included only women without gonorrhoea and, in second half of trial, women without
chlamydia
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Allocation concealment (selection bias) Low risk
Incomplete outcome data (attrition bias) High risk
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Lichtenberg 2003
Methods - Single centre, USA (Chicago)
- Study period November 1995 - May 1996
- Follow-up visit at 2 weeks
Participants - 800 women randomised, 530 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: breast feeding; allergy to tetracycline; current antibiotic therapy;
fever; symptoms of pelvic infection; lives > 50 miles away; non-English speaking
- Preoperative infections
1) History of PID: arm 1: 5/257, arm 2:13/273
2) Chlamydia: not reported
3) Gonorrhoea: not reported
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared with alternative regimens of the same antibiotic
- Intervention, arm 1: doxycycline 100 mg twice daily, oral (postoperative, 7 days)
- Control, arm 2: doxycycline 100 mg twice daily, oral (postoperative, 3 days)
Outcomes Pelvic infection defined as: pelvic pain plus temperature > 37.5 °C plus either uterine,
adnexal or abdominal tenderness
Notes Unclear if universal antibiotic prophylaxis according to protocol definition; no preoper-
ative screening but women on antibiotics with symptoms of pelvic infection at baseline
were excluded
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Allocation concealment (selection bias) Low risk
Incomplete outcome data (attrition bias) Low risk
Nielsen 1993
Methods - Single centre, Denmark
- Study period July 1986 - June 1988
- Follow-up visit after 2 weeks and 4 weeks
Participants - 1170 women randomised, 1073 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: allergy to treatment; neurological disease; antibiotics at the time of
abortion; positive testing for gonorrhoea; re-curettage; patients with insertion of IUD
- Preoperative infections:
1) History of PID: arm 1:149/525 , arm 2: 159/548
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Nielsen 1993 (Continued)
2) Chlamydia: not reported
3) Gonorrhoea: all patients tested and 10 women with positive culture excluded
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: ofloxacin 400 mg, oral (peri-operative, single dose)
- Control, arm 2: placebo
Outcomes Post-abortal PID defined as:
a) Patient seen at the follow-up visit after 2 weeks, 4 of the following: temperature > 38
°C; continued pelvic pain > 5 days; bleeding more than menstrual flow > 5 days; foul
discharge; infection diagnosed by general practitioner;
b) Patient seen before follow-up visit after 2 weeks, at least 2 of: temperature > 38 °C;
moderate tenderness of the uterus; tender adnexal mass; pathologic discharge or bleeding
Notes Not universal antibiotic prophylaxis according to protocol definition; study group in-
cluded only women without gonorrhoea at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias) High risk
Penney 1998
Methods - Multicentre (4 hospitals), Scotland
- Study period 1995 - 1996
- Follow-up during 8 weeks after surgery
Participants - 1672 women randomised, 1613 analysed (women with screening test results available)
- Women presenting for surgical abortion in first trimester
- Preoperative infections:
1) Chlamydia: all women tested, 91 positive (results according to allocation not available)
2) Gonorrhoea: all women tested, 3 positive (results according to allocation not available)
3) Bacterial vaginosis: all women tested, 282 positive (results according to allocation not
available)
Interventions Screen and treat compared to universal antibiotic prophylaxis
- Intervention, arm 1: screen and treat preoperatively if positive results for chlamydia
(doxycycline 100 mg twice daily, oral, 7 days), gonorrhoea (ciprofloxacin 250 mg single
dose, oral), bacterial vaginosis (metronidazole 400 mg twice daily, oral, 7 days)
- Intervention, arm 2: universal antibiotic prophylaxis, metronidazole 1 g single dose per
rectum peri-operative, immediately before; doxycycline 100 mg twice daily, oral, 7 days,
starting immediately after
Outcomes Suspected PID/endometritis reported by general practitioner: no criteria stated
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Penney 1998 (Continued)
Notes Universal antibiotic prophylaxis according to review protocol
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Allocation concealment (selection bias) Low risk
Incomplete outcome data (attrition bias) High risk
Sonne-Holm 1981
Methods - Multicentre (2 hospitals), Denmark (Copenhagen)
- Study period 1978-1979
- Follow-up visit after 4 weeks
Participants - 564 women randomised, 493 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: patients participating in another study; allergy to treatment; antibi-
otics indicated a priori;
Preoperative infections:
1) History of PID: arm 1: 47/254 , arm 2: 58/239
2) Chlamydia: not reported
3) Gonorrhoea: not reported
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: penicillin G 2 million IU 2 doses, intra-muscular (perioperative,
x 1 30 min before, x 1 3h after), pivampicillin 350 mg three times daily, oral, 4 days
(postoperative)
- Control, arm 2: placebo
Outcomes 1) Post-abortal infection defined as
a) Patient seen at follow-up visit after 4 weeks, at least 4 of the following: temperature >
38 °C for > 24h; continued pelvic pain > 5 days; vaginal bleeding more than menstrual
flow > 5 days; foul discharge; infection diagnosed by general practitioner
b) Patient seen before scheduled follow-up, at least 2 of the following: temperature >
38 °C; moderate tenderness of the uterus; tender adnexal mass; pathologic discharge or
bleeding
2) Adverse events of antibiotic treatment
Notes Unclear if intervention was universal antibiotic prophylaxis according to protocol defini-
tion; preoperative testing for infections not mentioned
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Sonne-Holm 1981 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias) High risk
Sorensen 1992
Methods - Single centre, Denmark
- Study period: October 1985 - March 1988
- Follow-up visits after 1 and 4 weeks
Participants - 432 women randomised, 378 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: allergic to treatment; receiving antibiotics at time of abortion; signs
of infection before abortion; positive test for gonorrhoea
Preoperative infections:
1) History of PID: arm 1: 50/189, arm 2: 40/189
2) Chlamydia: arm 1: 13/189 , arm 2: 14/189
3) Gonorrhoea: all tested, 3 women with positive tests excluded
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: erythromycin 500 mg twice daily, oral (pre-and postoperative,
starting on the evening before abortion, total 15 doses)
- Control, arm 2: placebo
Outcomes Postabortal PID defined as: pelvic pain plus at least 2 of the following: temperature
> 38 °C; tenderness of uterus; tenderness of tubes; adnexal mass; abnormal discharge;
abnormal bleeding
Notes Not universal antibiotic prophylaxis according to protocol definition: study population
included only women without gonorrhoea at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk
Allocation concealment (selection bias) Low risk
Incomplete outcome data (attrition bias) Low risk
42Perioperative antibiotics to prevent infection after first-trimester abortion (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Westrom 1981
Methods - Single centre, Sweden (Lund)
- Study period: September 1979 - March 1980
- Follow-up visit after 5 days
Participants - 278 women randomised, 212 analysed
- Women presenting for surgical abortion in first trimester
- Exclusion criteria: positive test for gonorrhoea; ongoing antibiotic treatment at the time
of abortion; abortion combined with hysterectomy
Preoperative infections:
1) History of PID: not reported
2) Chlamydia: not reported
3) Gonorrhoea: two patients testing positive excluded from analysis
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared to placebo
- Intervention, arm 1: tinidazole 2 g single dose, (oral preoperative, 12h before)
- Control, arm 2: placebo
Outcomes Post-abortion endometritis defined as all of the following: temperature > 38 °C in first 5
postoperative days; lower abdominal pain; tenderness of uterus
Notes Not universal antibiotic prophylaxis according to protocol definition: study population
included only women without gonorrhoea at baseline
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias) Low risk
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bennett 2009 Not a RCT (observational cohort study).
Blackwell 1993 Not a RCT (observational cohort study).
Chen 2007 Not a RCT (mathematical modelling study).
Cormier 1988 1. Includes participants post-partum as well as post-abortion; 2. Outcome is not PID, but isolation of
micro-organisms from curettage material
Faucher 2006 Not a RCT (narrative review).
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(Continued)
Gemzell-Danielsson 2008 1. Includes participants with mid-trimester abortion; 2. Not antibiotic prophylaxis
Giertz 1987 Includes participants after first-trimester.
Grossmann 2008 1. Includes participants with second-trimester abortion; 2. Not a RCT (narrative review)
Gupta 2007 Not a RCT (narrative review).
Heisterberg 1985c Outcome was post-abortal bacter aemia, not upper genital tract infection
Henriques 1994 Stratification of control group according to risk assessment post-randomisation, so not possible to analyse
as randomised comparison
May 2007 Not a RCT (systematic review of antibiotics for incomplete abortion)
Miller 2004 Only 51% of the participants were women undergoing first-trimester abortion and results not stratified
according to gestational age
Nguyen 2009 Not a RCT (observational cohort study).
Prager 2009 1. Includes participants with second-trimester abortion; 2. Not a RCT (systematic review)
Spence 1982 Participants were in second-trimester of pregnancy.
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D A T A A N D A N A L Y S E S
Comparison 1. All included studies, 19 trials: by intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Control arm and strategy 19 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Antibiotic prophylaxis vs.
placebo
15 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Antibiotic prophylaxis vs.
alternative regimen(s)
3 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.3 Screen-and-treat vs.
universal antibiotic prophylaxis
1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
Comparison 2. Antibiotics vs placebo, 15 trials: by universal prophylaxis
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Type of antibiotic prophylaxis 15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Universal prophylaxis 1 769 Risk Ratio (M-H, Random, 95% CI) 0.33 [0.15, 0.73]
1.2 Not universal prophylaxis 10 5168 Risk Ratio (M-H, Random, 95% CI) 0.65 [0.49, 0.87]
1.3 Unclear if universal
prophylaxis
4 1088 Risk Ratio (M-H, Random, 95% CI) 0.49 [0.32, 0.75]
Comparison 3. Antibiotics vs. placebo, 15 trials: by class of antibiotic
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotic class 15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Nitromidazole 6 1087 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.37, 0.77]
1.2 Tetracycline 4 2433 Risk Ratio (M-H, Random, 95% CI) 0.37 [0.14, 0.98]
1.3 Beta lactam 2 778 Risk Ratio (M-H, Random, 95% CI) 0.52 [0.31, 0.88]
1.4 Fluoroquinolone 1 1073 Risk Ratio (M-H, Random, 95% CI) 0.79 [0.57, 1.09]
1.5 Macrolide 1 378 Risk Ratio (M-H, Random, 95% CI) 0.67 [0.39, 1.13]
1.6 Glycoside 1 1276 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.57, 1.53]
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Comparison 4. Antibiotics vs. placebo, 15 trials: by route of antibiotic administration
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Route of antibiotic
administration
15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Oral 12 5191 Risk Ratio (M-H, Random, 95% CI) 0.54 [0.40, 0.74]
1.2 Intravenous 1 285 Risk Ratio (M-H, Random, 95% CI) 0.56 [0.23, 1.39]
1.3 Rectal 1 273 Risk Ratio (M-H, Random, 95% CI) 0.53 [0.27, 1.03]
1.4 Vaginal 1 1276 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.57, 1.53]
Comparison 5. Antibiotics vs. placebo, 15 trials: by timing of antibiotic administration
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Timing of antibiotic
administration
15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Pre-operative 4 2467 Risk Ratio (M-H, Random, 95% CI) 0.62 [0.39, 0.98]
1.2 Perioperative 6 2926 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.28, 0.83]
1.3 Peri- and post-operative 1 493 Risk Ratio (M-H, Random, 95% CI) 0.51 [0.27, 0.95]
1.4 Pre- and post-operative 4 1139 Risk Ratio (M-H, Random, 95% CI) 0.67 [0.43, 1.06]
Comparison 6. Antibiotics vs. placebo, 15 trials: by dosing schedule
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Antibiotic dosing schedule 15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Single dose 6 2822 Risk Ratio (M-H, Random, 95% CI) 0.64 [0.51, 0.82]
1.2 Multiple doses on the day
of abortion
3 1295 Risk Ratio (M-H, Random, 95% CI) 0.28 [0.07, 1.06]
1.3 Multiple doses over several
days
6 2908 Risk Ratio (M-H, Random, 95% CI) 0.70 [0.52, 0.96]
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Comparison 7. Women with a history of pelvic inflammatory disease (PID), 5 trials
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 PID stratified according to
previous history of PID
5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 PID in women with
previous history of PID
5 692 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.32, 0.96]
1.2 PID in women without
previous history of PID
5 2120 Risk Ratio (M-H, Random, 95% CI) 0.66 [0.45, 0.96]
Comparison 8. Women with chlamydia at baseline, 2 trials
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 PID stratified according to
positive chlamydia testing
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 PID in women with
positive chlamydia testing
2 101 Risk Ratio (M-H, Random, 95% CI) 0.14 [0.04, 0.58]
1.2 PID in women with
negative chlamydia testing
2 1353 Risk Ratio (M-H, Random, 95% CI) 0.37 [0.06, 2.19]
Comparison 9. Antibiotics, vs. placebo, 15 trials: by reported analysis of outcome data
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Dealing with incomplete
outcome data
15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Incomplete outcome data
addressed adequately
8 2437 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.44, 0.82]
1.2 Incomplete outcome data
not addressed adequately
7 4588 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.37, 0.83]
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Comparison 10. Antibiotics vs. placebo, 15 trials: by reporting of allocation concealment
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Concealment of allocation 15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Adequate allocation
concealment
4 2497 Risk Ratio (M-H, Random, 95% CI) 0.40 [0.21, 0.74]
1.2 Inadequate allocation
concealment
11 4528 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.58, 0.87]
Comparison 11. Antibiotics vs. placebo, 15 trials: by reporting of blinding
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Reported blinding 15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Double blind 13 5459 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.41, 0.74]
1.2 Not double blind 2 1566 Risk Ratio (M-H, Random, 95% CI) 0.69 [0.46, 1.02]
Comparison 12. Antibiotics vs. placebo, 15 trials: by reporting of random sequence generation method
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Random sequence generation
method
15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Adequate random
sequence generation
10 4541 Risk Ratio (M-H, Random, 95% CI) 0.51 [0.36, 0.73]
1.2 Inadequate random
sequence generation
5 2484 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.53, 0.94]
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Analysis 1.1. Comparison 1 All included studies, 19 trials: by intervention, Outcome 1 Control arm and
strategy.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 1 All included studies, 19 trials: by intervention
Outcome: 1 Control arm and strategy
Study or subgroup Intervention Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Antibiotic prophylaxis vs. placebo
Crowley 2001 12/142 21/131 0.53 [ 0.27, 1.03 ]
Darj 1987 8/386 24/383 0.33 [ 0.15, 0.73 ]
Heisterberg 1985a 25/269 25/263 0.98 [ 0.58, 1.66 ]
Heisterberg 1985b 2/51 10/49 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 0.84 [ 0.32, 2.26 ]
Heisterberg 1988 2/24 7/31 0.37 [ 0.08, 1.62 ]
Krohn 1981 6/104 11/106 0.56 [ 0.21, 1.45 ]
Krohn 1986 7/145 12/140 0.56 [ 0.23, 1.39 ]
Larsson 1992 3/84 11/90 0.29 [ 0.08, 1.01 ]
Larsson 2000 29/650 30/626 0.93 [ 0.57, 1.53 ]
Levallois 1988 3/536 26/541 0.12 [ 0.04, 0.38 ]
Nielsen 1993 55/525 73/548 0.79 [ 0.57, 1.09 ]
Sonne-Holm 1981 14/254 26/239 0.51 [ 0.27, 0.95 ]
Sorensen 1992 20/189 30/189 0.67 [ 0.39, 1.13 ]
Westrom 1981 10/102 17/110 0.63 [ 0.30, 1.32 ]
2 Antibiotic prophylaxis vs. alternative regimen(s)
Caruso 2008 16/153 11/155 1.47 [ 0.71, 3.07 ]
Caruso 2008 16/153 4/158 4.13 [ 1.41, 12.08 ]
Heisterberg 1986 8/43 5/38 1.41 [ 0.51, 3.96 ]
Lichtenberg 2003 1/257 0/273 3.19 [ 0.13, 77.86 ]
3 Screen-and-treat vs. universal antibiotic prophylaxis
Penney 1998 51/836 31/777 1.53 [ 0.99, 2.36 ]
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Analysis 2.1. Comparison 2 Antibiotics vs placebo, 15 trials: by universal prophylaxis, Outcome 1 Type of
antibiotic prophylaxis.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 2 Antibiotics vs placebo, 15 trials: by universal prophylaxis
Outcome: 1 Type of antibiotic prophylaxis
Study or subgroup Antibiotic Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Universal prophylaxis
Darj 1987 8/386 24/383 100.0 % 0.33 [ 0.15, 0.73 ]
Subtotal (95% CI) 386 383 100.0 % 0.33 [ 0.15, 0.73 ]
Total events: 8 (Antibiotic), 24 (Placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 2.75 (P = 0.0059)
2 Not universal prophylaxis
Crowley 2001 12/142 21/131 10.7 % 0.53 [ 0.27, 1.03 ]
Heisterberg 1985a 25/269 25/263 13.7 % 0.98 [ 0.58, 1.66 ]
Heisterberg 1987 7/64 7/54 6.3 % 0.84 [ 0.32, 2.26 ]
Heisterberg 1988 2/24 7/31 3.2 % 0.37 [ 0.08, 1.62 ]
Larsson 1992 3/84 11/90 4.3 % 0.29 [ 0.08, 1.01 ]
Larsson 2000 29/650 30/626 14.5 % 0.93 [ 0.57, 1.53 ]
Levallois 1988 3/536 26/541 4.7 % 0.12 [ 0.04, 0.38 ]
Nielsen 1993 55/525 73/548 19.4 % 0.79 [ 0.57, 1.09 ]
Sorensen 1992 20/189 30/189 13.7 % 0.67 [ 0.39, 1.13 ]
Westrom 1981 10/102 17/110 9.5 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 2585 2583 100.0 % 0.65 [ 0.49, 0.87 ]
Total events: 166 (Antibiotic), 247 (Placebo)
Heterogeneity: Tau2 = 0.08; Chi2 = 15.84, df = 9 (P = 0.07); I2 =43%
Test for overall effect: Z = 2.93 (P = 0.0034)
3 Unclear if universal prophylaxis
Heisterberg 1985b 2/51 10/49 8.7 % 0.19 [ 0.04, 0.83 ]
Krohn 1981 6/104 11/106 20.4 % 0.56 [ 0.21, 1.45 ]
Krohn 1986 7/145 12/140 23.0 % 0.56 [ 0.23, 1.39 ]
Sonne-Holm 1981 14/254 26/239 47.9 % 0.51 [ 0.27, 0.95 ]
Subtotal (95% CI) 554 534 100.0 % 0.49 [ 0.32, 0.75 ]
Total events: 29 (Antibiotic), 59 (Placebo)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.75, df = 3 (P = 0.63); I2 =0.0%
Test for overall effect: Z = 3.27 (P = 0.0011)
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Analysis 3.1. Comparison 3 Antibiotics vs. placebo, 15 trials: by class of antibiotic, Outcome 1 Antibiotic
class.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 3 Antibiotics vs. placebo, 15 trials: by class of antibiotic
Outcome: 1 Antibiotic class
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Nitromidazole
Crowley 2001 12/142 21/131 30.5 % 0.53 [ 0.27, 1.03 ]
Heisterberg 1985b 2/51 10/49 6.3 % 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 14.1 % 0.84 [ 0.32, 2.26 ]
Krohn 1981 6/104 11/106 14.9 % 0.56 [ 0.21, 1.45 ]
Larsson 1992 3/84 11/90 8.8 % 0.29 [ 0.08, 1.01 ]
Westrom 1981 10/102 17/110 25.3 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 547 540 100.0 % 0.53 [ 0.37, 0.77 ]
Total events: 40 (Antibiotics), 77 (Placebo)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.87, df = 5 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 3.37 (P = 0.00074)
2 Tetracycline
Darj 1987 8/386 24/383 27.7 % 0.33 [ 0.15, 0.73 ]
Heisterberg 1985a 25/269 25/263 30.8 % 0.98 [ 0.58, 1.66 ]
Heisterberg 1988 2/24 7/31 19.0 % 0.37 [ 0.08, 1.62 ]
Levallois 1988 3/536 26/541 22.5 % 0.12 [ 0.04, 0.38 ]
Subtotal (95% CI) 1215 1218 100.0 % 0.37 [ 0.14, 0.98 ]
Total events: 38 (Antibiotics), 82 (Placebo)
Heterogeneity: Tau2 = 0.72; Chi2 = 13.61, df = 3 (P = 0.003); I2 =78%
Test for overall effect: Z = 1.99 (P = 0.046)
3 Beta lactam
Krohn 1986 7/145 12/140 32.4 % 0.56 [ 0.23, 1.39 ]
Sonne-Holm 1981 14/254 26/239 67.6 % 0.51 [ 0.27, 0.95 ]
Subtotal (95% CI) 399 379 100.0 % 0.52 [ 0.31, 0.88 ]
Total events: 21 (Antibiotics), 38 (Placebo)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 2.46 (P = 0.014)
4 Fluoroquinolone
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Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Nielsen 1993 55/525 73/548 100.0 % 0.79 [ 0.57, 1.09 ]
Subtotal (95% CI) 525 548 100.0 % 0.79 [ 0.57, 1.09 ]
Total events: 55 (Antibiotics), 73 (Placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 1.43 (P = 0.15)
5 Macrolide
Sorensen 1992 20/189 30/189 100.0 % 0.67 [ 0.39, 1.13 ]
Subtotal (95% CI) 189 189 100.0 % 0.67 [ 0.39, 1.13 ]
Total events: 20 (Antibiotics), 30 (Placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 1.50 (P = 0.13)
6 Glycoside
Larsson 2000 29/650 30/626 100.0 % 0.93 [ 0.57, 1.53 ]
Subtotal (95% CI) 650 626 100.0 % 0.93 [ 0.57, 1.53 ]
Total events: 29 (Antibiotics), 30 (Placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
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Analysis 4.1. Comparison 4 Antibiotics vs. placebo, 15 trials: by route of antibiotic administration, Outcome
1 Route of antibiotic administration.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 4 Antibiotics vs. placebo, 15 trials: by route of antibiotic administration
Outcome: 1 Route of antibiotic administration
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Oral
Darj 1987 8/386 24/383 8.5 % 0.33 [ 0.15, 0.73 ]
Heisterberg 1985a 25/269 25/263 12.6 % 0.98 [ 0.58, 1.66 ]
Heisterberg 1985b 2/51 10/49 3.5 % 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 6.4 % 0.84 [ 0.32, 2.26 ]
Heisterberg 1988 2/24 7/31 3.4 % 0.37 [ 0.08, 1.62 ]
Krohn 1981 6/104 11/106 6.7 % 0.56 [ 0.21, 1.45 ]
Larsson 1992 3/84 11/90 4.6 % 0.29 [ 0.08, 1.01 ]
Levallois 1988 3/536 26/541 4.9 % 0.12 [ 0.04, 0.38 ]
Nielsen 1993 55/525 73/548 16.6 % 0.79 [ 0.57, 1.09 ]
Sonne-Holm 1981 14/254 26/239 10.9 % 0.51 [ 0.27, 0.95 ]
Sorensen 1992 20/189 30/189 12.6 % 0.67 [ 0.39, 1.13 ]
Westrom 1981 10/102 17/110 9.3 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 2588 2603 100.0 % 0.54 [ 0.40, 0.74 ]
Total events: 155 (Antibiotics), 267 (Placebo)
Heterogeneity: Tau2 = 0.11; Chi2 = 20.62, df = 11 (P = 0.04); I2 =47%
Test for overall effect: Z = 3.97 (P = 0.000073)
2 Intravenous
Krohn 1986 7/145 12/140 100.0 % 0.56 [ 0.23, 1.39 ]
Subtotal (95% CI) 145 140 100.0 % 0.56 [ 0.23, 1.39 ]
Total events: 7 (Antibiotics), 12 (Placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 1.25 (P = 0.21)
3 Rectal
Crowley 2001 12/142 21/131 100.0 % 0.53 [ 0.27, 1.03 ]
Subtotal (95% CI) 142 131 100.0 % 0.53 [ 0.27, 1.03 ]
Total events: 12 (Antibiotics), 21 (Placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 1.88 (P = 0.060)
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Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
4 Vaginal
Larsson 2000 29/650 30/626 100.0 % 0.93 [ 0.57, 1.53 ]
Subtotal (95% CI) 650 626 100.0 % 0.93 [ 0.57, 1.53 ]
Total events: 29 (Antibiotics), 30 (Placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
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Analysis 5.1. Comparison 5 Antibiotics vs. placebo, 15 trials: by timing of antibiotic administration,
Outcome 1 Timing of antibiotic administration.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 5 Antibiotics vs. placebo, 15 trials: by timing of antibiotic administration
Outcome: 1 Timing of antibiotic administration
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Pre-operative
Darj 1987 8/386 24/383 22.2 % 0.33 [ 0.15, 0.73 ]
Krohn 1981 6/104 11/106 16.9 % 0.56 [ 0.21, 1.45 ]
Larsson 2000 29/650 30/626 36.5 % 0.93 [ 0.57, 1.53 ]
Westrom 1981 10/102 17/110 24.3 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 1242 1225 100.0 % 0.62 [ 0.39, 0.98 ]
Total events: 53 (Antibiotics), 82 (Placebo)
Heterogeneity: Tau2 = 0.09; Chi2 = 4.94, df = 3 (P = 0.18); I2 =39%
Test for overall effect: Z = 2.06 (P = 0.040)
2 Perioperative
Crowley 2001 12/142 21/131 20.5 % 0.53 [ 0.27, 1.03 ]
Heisterberg 1985b 2/51 10/49 9.2 % 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 14.9 % 0.84 [ 0.32, 2.26 ]
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Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Krohn 1986 7/145 12/140 16.2 % 0.56 [ 0.23, 1.39 ]
Levallois 1988 3/536 26/541 12.1 % 0.12 [ 0.04, 0.38 ]
Nielsen 1993 55/525 73/548 27.1 % 0.79 [ 0.57, 1.09 ]
Subtotal (95% CI) 1463 1463 100.0 % 0.48 [ 0.28, 0.83 ]
Total events: 86 (Antibiotics), 149 (Placebo)
Heterogeneity: Tau2 = 0.25; Chi2 = 13.18, df = 5 (P = 0.02); I2 =62%
Test for overall effect: Z = 2.66 (P = 0.0077)
3 Peri- and post-operative
Sonne-Holm 1981 14/254 26/239 100.0 % 0.51 [ 0.27, 0.95 ]
Subtotal (95% CI) 254 239 100.0 % 0.51 [ 0.27, 0.95 ]
Total events: 14 (Antibiotics), 26 (Placebo)
Heterogeneity: not applicable
Test for overall effect: Z = 2.13 (P = 0.033)
4 Pre- and post-operative
Heisterberg 1985a 25/269 25/263 40.0 % 0.98 [ 0.58, 1.66 ]
Heisterberg 1988 2/24 7/31 8.5 % 0.37 [ 0.08, 1.62 ]
Larsson 1992 3/84 11/90 11.6 % 0.29 [ 0.08, 1.01 ]
Sorensen 1992 20/189 30/189 39.9 % 0.67 [ 0.39, 1.13 ]
Subtotal (95% CI) 566 573 100.0 % 0.67 [ 0.43, 1.06 ]
Total events: 50 (Antibiotics), 73 (Placebo)
Heterogeneity: Tau2 = 0.06; Chi2 = 4.21, df = 3 (P = 0.24); I2 =29%
Test for overall effect: Z = 1.72 (P = 0.086)
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Analysis 6.1. Comparison 6 Antibiotics vs. placebo, 15 trials: by dosing schedule, Outcome 1 Antibiotic
dosing schedule.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 6 Antibiotics vs. placebo, 15 trials: by dosing schedule
Outcome: 1 Antibiotic dosing schedule
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single dose
Crowley 2001 12/142 21/131 13.0 % 0.53 [ 0.27, 1.03 ]
Darj 1987 8/386 24/383 9.3 % 0.33 [ 0.15, 0.73 ]
Krohn 1981 6/104 11/106 6.3 % 0.56 [ 0.21, 1.45 ]
Krohn 1986 7/145 12/140 7.1 % 0.56 [ 0.23, 1.39 ]
Nielsen 1993 55/525 73/548 53.5 % 0.79 [ 0.57, 1.09 ]
Westrom 1981 10/102 17/110 10.8 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 1404 1418 100.0 % 0.64 [ 0.51, 0.82 ]
Total events: 98 (Antibiotics), 158 (Placebo)
Heterogeneity: Tau2 = 0.0; Chi2 = 4.71, df = 5 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 3.60 (P = 0.00032)
2 Multiple doses on the day of abortion
Heisterberg 1985b 2/51 10/49 29.6 % 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 36.8 % 0.84 [ 0.32, 2.26 ]
Levallois 1988 3/536 26/541 33.7 % 0.12 [ 0.04, 0.38 ]
Subtotal (95% CI) 651 644 100.0 % 0.28 [ 0.07, 1.06 ]
Total events: 12 (Antibiotics), 43 (Placebo)
Heterogeneity: Tau2 = 1.01; Chi2 = 7.42, df = 2 (P = 0.02); I2 =73%
Test for overall effect: Z = 1.87 (P = 0.061)
3 Multiple doses over several days
Heisterberg 1985a 25/269 25/263 23.4 % 0.98 [ 0.58, 1.66 ]
Heisterberg 1988 2/24 7/31 4.1 % 0.37 [ 0.08, 1.62 ]
Larsson 1992 3/84 11/90 5.7 % 0.29 [ 0.08, 1.01 ]
Larsson 2000 29/650 30/626 25.3 % 0.93 [ 0.57, 1.53 ]
Sonne-Holm 1981 14/254 26/239 18.3 % 0.51 [ 0.27, 0.95 ]
Sorensen 1992 20/189 30/189 23.3 % 0.67 [ 0.39, 1.13 ]
Subtotal (95% CI) 1470 1438 100.0 % 0.70 [ 0.52, 0.96 ]
Total events: 93 (Antibiotics), 129 (Placebo)
Heterogeneity: Tau2 = 0.03; Chi2 = 6.43, df = 5 (P = 0.27); I2 =22%
Test for overall effect: Z = 2.25 (P = 0.024)
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Analysis 7.1. Comparison 7 Women with a history of pelvic inflammatory disease (PID), 5 trials, Outcome
1 PID stratified according to previous history of PID.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 7 Women with a history of pelvic inflammatory disease (PID), 5 trials
Outcome: 1 PID stratified according to previous history of PID
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PID in women with previous history of PID
Darj 1987 3/80 9/84 14.9 % 0.35 [ 0.10, 1.25 ]
Heisterberg 1985b 2/13 4/12 11.3 % 0.46 [ 0.10, 2.08 ]
Nielsen 1993 20/149 27/159 43.1 % 0.79 [ 0.46, 1.35 ]
Sonne-Holm 1981 1/47 13/58 6.9 % 0.09 [ 0.01, 0.70 ]
Sorensen 1992 7/50 8/40 23.8 % 0.70 [ 0.28, 1.77 ]
Subtotal (95% CI) 339 353 100.0 % 0.55 [ 0.32, 0.96 ]
Total events: 33 (Antibiotics), 61 (Placebo)
Heterogeneity: Tau2 = 0.11; Chi2 = 5.51, df = 4 (P = 0.24); I2 =27%
Test for overall effect: Z = 2.11 (P = 0.035)
2 PID in women without previous history of PID
Darj 1987 5/302 15/303 12.4 % 0.33 [ 0.12, 0.91 ]
Heisterberg 1985b 0/38 6/37 1.8 % 0.07 [ 0.00, 1.28 ]
Nielsen 1993 35/376 46/389 41.4 % 0.79 [ 0.52, 1.19 ]
Sonne-Holm 1981 13/207 13/180 20.0 % 0.87 [ 0.41, 1.83 ]
Sorensen 1992 13/139 22/149 24.5 % 0.63 [ 0.33, 1.21 ]
Subtotal (95% CI) 1062 1058 100.0 % 0.66 [ 0.45, 0.96 ]
Total events: 66 (Antibiotics), 102 (Placebo)
Heterogeneity: Tau2 = 0.05; Chi2 = 5.30, df = 4 (P = 0.26); I2 =25%
Test for overall effect: Z = 2.15 (P = 0.031)
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Analysis 8.1. Comparison 8 Women with chlamydia at baseline, 2 trials, Outcome 1 PID stratified
according to positive chlamydia testing.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 8 Women with chlamydia at baseline, 2 trials
Outcome: 1 PID stratified according to positive chlamydia testing
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 PID in women with positive chlamydia testing
Levallois 1988 1/33 11/41 49.6 % 0.11 [ 0.02, 0.83 ]
Sorensen 1992 1/13 6/14 50.4 % 0.18 [ 0.02, 1.30 ]
Subtotal (95% CI) 46 55 100.0 % 0.14 [ 0.04, 0.58 ]
Total events: 2 (Antibiotics), 17 (Placebo)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 2.72 (P = 0.0066)
2 PID in women with negative chlamydia testing
Levallois 1988 2/503 15/499 42.9 % 0.13 [ 0.03, 0.58 ]
Sorensen 1992 19/176 24/175 57.1 % 0.79 [ 0.45, 1.38 ]
Subtotal (95% CI) 679 674 100.0 % 0.37 [ 0.06, 2.19 ]
Total events: 21 (Antibiotics), 39 (Placebo)
Heterogeneity: Tau2 = 1.38; Chi2 = 5.27, df = 1 (P = 0.02); I2 =81%
Test for overall effect: Z = 1.10 (P = 0.27)
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Analysis 9.1. Comparison 9 Antibiotics, vs. placebo, 15 trials: by reported analysis of outcome data,
Outcome 1 Dealing with incomplete outcome data.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 9 Antibiotics, vs. placebo, 15 trials: by reported analysis of outcome data
Outcome: 1 Dealing with incomplete outcome data
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Incomplete outcome data addressed adequately
Crowley 2001 12/142 21/131 15.5 % 0.53 [ 0.27, 1.03 ]
Darj 1987 8/386 24/383 12.0 % 0.33 [ 0.15, 0.73 ]
Heisterberg 1985a 25/269 25/263 21.4 % 0.98 [ 0.58, 1.66 ]
Heisterberg 1985b 2/51 10/49 4.1 % 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 8.3 % 0.84 [ 0.32, 2.26 ]
Heisterberg 1988 2/24 7/31 4.0 % 0.37 [ 0.08, 1.62 ]
Sorensen 1992 20/189 30/189 21.3 % 0.67 [ 0.39, 1.13 ]
Westrom 1981 10/102 17/110 13.4 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 1227 1210 100.0 % 0.60 [ 0.44, 0.82 ]
Total events: 86 (Antibiotics), 141 (Placebo)
Heterogeneity: Tau2 = 0.04; Chi2 = 8.98, df = 7 (P = 0.25); I2 =22%
Test for overall effect: Z = 3.23 (P = 0.0012)
2 Incomplete outcome data not addressed adequately
Krohn 1981 6/104 11/106 11.1 % 0.56 [ 0.21, 1.45 ]
Krohn 1986 7/145 12/140 11.9 % 0.56 [ 0.23, 1.39 ]
Larsson 1992 3/84 11/90 7.8 % 0.29 [ 0.08, 1.01 ]
Larsson 2000 29/650 30/626 19.9 % 0.93 [ 0.57, 1.53 ]
Levallois 1988 3/536 26/541 8.3 % 0.12 [ 0.04, 0.38 ]
Nielsen 1993 55/525 73/548 24.0 % 0.79 [ 0.57, 1.09 ]
Sonne-Holm 1981 14/254 26/239 17.0 % 0.51 [ 0.27, 0.95 ]
Subtotal (95% CI) 2298 2290 100.0 % 0.55 [ 0.37, 0.83 ]
Total events: 117 (Antibiotics), 189 (Placebo)
Heterogeneity: Tau2 = 0.15; Chi2 = 14.02, df = 6 (P = 0.03); I2 =57%
Test for overall effect: Z = 2.87 (P = 0.0042)
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Analysis 10.1. Comparison 10 Antibiotics vs. placebo, 15 trials: by reporting of allocation concealment,
Outcome 1 Concealment of allocation.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 10 Antibiotics vs. placebo, 15 trials: by reporting of allocation concealment
Outcome: 1 Concealment of allocation
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Adequate allocation concealment
Crowley 2001 12/142 21/131 27.7 % 0.53 [ 0.27, 1.03 ]
Darj 1987 8/386 24/383 24.6 % 0.33 [ 0.15, 0.73 ]
Levallois 1988 3/536 26/541 16.3 % 0.12 [ 0.04, 0.38 ]
Sorensen 1992 20/189 30/189 31.4 % 0.67 [ 0.39, 1.13 ]
Subtotal (95% CI) 1253 1244 100.0 % 0.40 [ 0.21, 0.74 ]
Total events: 43 (Antibiotics), 101 (Placebo)
Heterogeneity: Tau2 = 0.25; Chi2 = 8.24, df = 3 (P = 0.04); I2 =64%
Test for overall effect: Z = 2.93 (P = 0.0034)
2 Inadequate allocation concealment
Heisterberg 1985a 25/269 25/263 14.1 % 0.98 [ 0.58, 1.66 ]
Heisterberg 1985b 2/51 10/49 2.0 % 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 4.3 % 0.84 [ 0.32, 2.26 ]
Heisterberg 1988 2/24 7/31 1.9 % 0.37 [ 0.08, 1.62 ]
Krohn 1981 6/104 11/106 4.5 % 0.56 [ 0.21, 1.45 ]
Krohn 1986 7/145 12/140 5.1 % 0.56 [ 0.23, 1.39 ]
Larsson 1992 3/84 11/90 2.7 % 0.29 [ 0.08, 1.01 ]
Larsson 2000 29/650 30/626 15.6 % 0.93 [ 0.57, 1.53 ]
Nielsen 1993 55/525 73/548 31.9 % 0.79 [ 0.57, 1.09 ]
Sonne-Holm 1981 14/254 26/239 10.3 % 0.51 [ 0.27, 0.95 ]
Westrom 1981 10/102 17/110 7.6 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 2272 2256 100.0 % 0.71 [ 0.58, 0.87 ]
Total events: 160 (Antibiotics), 229 (Placebo)
Heterogeneity: Tau2 = 0.01; Chi2 = 10.56, df = 10 (P = 0.39); I2 =5%
Test for overall effect: Z = 3.26 (P = 0.0011)
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Analysis 11.1. Comparison 11 Antibiotics vs. placebo, 15 trials: by reporting of blinding, Outcome 1
Reported blinding.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 11 Antibiotics vs. placebo, 15 trials: by reporting of blinding
Outcome: 1 Reported blinding
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Double blind
Crowley 2001 12/142 21/131 9.9 % 0.53 [ 0.27, 1.03 ]
Darj 1987 8/386 24/383 8.3 % 0.33 [ 0.15, 0.73 ]
Heisterberg 1985a 25/269 25/263 12.2 % 0.98 [ 0.58, 1.66 ]
Heisterberg 1985b 2/51 10/49 3.4 % 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 6.3 % 0.84 [ 0.32, 2.26 ]
Heisterberg 1988 2/24 7/31 3.4 % 0.37 [ 0.08, 1.62 ]
Krohn 1981 6/104 11/106 6.5 % 0.56 [ 0.21, 1.45 ]
Krohn 1986 7/145 12/140 7.0 % 0.56 [ 0.23, 1.39 ]
Larsson 1992 3/84 11/90 4.5 % 0.29 [ 0.08, 1.01 ]
Larsson 2000 29/650 30/626 12.7 % 0.93 [ 0.57, 1.53 ]
Levallois 1988 3/536 26/541 4.8 % 0.12 [ 0.04, 0.38 ]
Sorensen 1992 20/189 30/189 12.2 % 0.67 [ 0.39, 1.13 ]
Westrom 1981 10/102 17/110 9.0 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 2746 2713 100.0 % 0.55 [ 0.41, 0.74 ]
Total events: 134 (Antibiotics), 231 (Placebo)
Heterogeneity: Tau2 = 0.12; Chi2 = 21.00, df = 12 (P = 0.05); I2 =43%
Test for overall effect: Z = 3.90 (P = 0.000095)
2 Not double blind
Nielsen 1993 55/525 73/548 69.0 % 0.79 [ 0.57, 1.09 ]
Sonne-Holm 1981 14/254 26/239 31.0 % 0.51 [ 0.27, 0.95 ]
Subtotal (95% CI) 779 787 100.0 % 0.69 [ 0.46, 1.02 ]
Total events: 69 (Antibiotics), 99 (Placebo)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.49, df = 1 (P = 0.22); I2 =33%
Test for overall effect: Z = 1.85 (P = 0.064)
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Analysis 12.1. Comparison 12 Antibiotics vs. placebo, 15 trials: by reporting of random sequence
generation method, Outcome 1 Random sequence generation method.
Review: Perioperative antibiotics to prevent infection after first-trimester abortion
Comparison: 12 Antibiotics vs. placebo, 15 trials: by reporting of random sequence generation method
Outcome: 1 Random sequence generation method
Study or subgroup Antibiotics Placebo Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Adequate random sequence generation
Crowley 2001 12/142 21/131 13.2 % 0.53 [ 0.27, 1.03 ]
Darj 1987 8/386 24/383 11.2 % 0.33 [ 0.15, 0.73 ]
Heisterberg 1985b 2/51 10/49 4.8 % 0.19 [ 0.04, 0.83 ]
Heisterberg 1987 7/64 7/54 8.6 % 0.84 [ 0.32, 2.26 ]
Heisterberg 1988 2/24 7/31 4.7 % 0.37 [ 0.08, 1.62 ]
Krohn 1981 6/104 11/106 8.9 % 0.56 [ 0.21, 1.45 ]
Krohn 1986 7/145 12/140 9.6 % 0.56 [ 0.23, 1.39 ]
Larsson 2000 29/650 30/626 16.6 % 0.93 [ 0.57, 1.53 ]
Levallois 1988 3/536 26/541 6.6 % 0.12 [ 0.04, 0.38 ]
Sorensen 1992 20/189 30/189 15.9 % 0.67 [ 0.39, 1.13 ]
Subtotal (95% CI) 2291 2250 100.0 % 0.51 [ 0.36, 0.73 ]
Total events: 96 (Antibiotics), 178 (Placebo)
Heterogeneity: Tau2 = 0.14; Chi2 = 16.26, df = 9 (P = 0.06); I2 =45%
Test for overall effect: Z = 3.70 (P = 0.00022)
2 Inadequate random sequence generation
Heisterberg 1985a 25/269 25/263 22.4 % 0.98 [ 0.58, 1.66 ]
Larsson 1992 3/84 11/90 4.9 % 0.29 [ 0.08, 1.01 ]
Nielsen 1993 55/525 73/548 42.8 % 0.79 [ 0.57, 1.09 ]
Sonne-Holm 1981 14/254 26/239 17.0 % 0.51 [ 0.27, 0.95 ]
Westrom 1981 10/102 17/110 13.0 % 0.63 [ 0.30, 1.32 ]
Subtotal (95% CI) 1234 1250 100.0 % 0.71 [ 0.53, 0.94 ]
Total events: 107 (Antibiotics), 152 (Placebo)
Heterogeneity: Tau2 = 0.02; Chi2 = 4.93, df = 4 (P = 0.29); I2 =19%
Test for overall effect: Z = 2.38 (P = 0.017)
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A D D I T I O N A L T A B L E S
Table 1. Testing and reporting of sexually transmitted infections and bacterial vaginosis
First au-
thor,
year
N PID as-
sess-
ment
strategy
No. with
history
of PID
Chlamy-
dia
testing
strategy
(method)
No. with
chlamy-
dia
Gonor-
rhoea
testing
strategy
(method)
No. with
gonor-
rhoea
BV
testing
strategy
(method)
No. with
BV
Antibi-
otics
used
Univer-
sal
antibi-
otic pro-
phylaxis
Antibiotic prophylaxis vs. placebo
Crowley
2001
273 Asked
pre-op
14 All tested
(EIA)
21 (%) Some
tested
(culture)
1 All tested
(Gram
stain)
273 Sin-
gle dose
metron-
idazole
No. ’All
women
with
chlamy-
dia were
treated
preoper-
atively.’
Darj
1987
769 Asked
pre-op
164 Not
tested
Not
tested
Not
tested
Not
tested
n.r. n.r. Sin-
gle dose
doxycy-
cline
Yes. ’Pre-
oper-
ative cul-
tures for
N. gonor-
rhoeae
and C.
tra-
chomatis
were not
made.’
Heister-
berg
1985b
532 Asked
pre-op
n.r. All tested
(culture)
48 (9.
0%)
All tested
(culture)
0 (all ex-
cluded)
n.r. n.r. Multi-
ple doses
lymecy-
cline
No. ’6
women
with pos-
itive cul-
tures for
N. gonor-
rhoeae
were
treated
and ex-
cluded.’
Heister-
berg
1985c
100 Physi-
cian di-
agnosis
25 n.r. n.r. All tested
(culture)
0
(no pos-
itive cul-
tures)
All tested
(culture)
19 (19.
0%)
Multi-
ple doses
metron-
idazole
Unclear
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Table 1. Testing and reporting of sexually transmitted infections and bacterial vaginosis (Continued)
Heister-
berg
1987
118 Physi-
cian di-
agnosis
118 n.r. n.r. All tested
(culture)
2 (1.7%) All tested
(culture)
41 (34.
7%)
Multi-
ple doses
metron-
idazole
No. ’2
women
had pos-
itive cul-
tures for
N. gonor-
rhoeae
and
received
peni-
cillin
prior
to abor-
tion.’
Heister-
berg
1988
55 Asked
pre-op
55 All tested
(culture)
3 (5.5%) All tested
(culture)
0 (all ex-
cluded)
n.r. n.r. Multi-
ple doses
lymecy-
cline
No. ’cul-
tures
were
made for
N. gonor-
rhoeae
and
women
with pos-
itive re-
sults
were
treated
and ex-
cluded.’
Krohn
1981
210 n.r. n.r. n.r. n.r. All tested
(culture)
n.r. All tested
(culture)
n.r. Sin-
gle dose
tinida-
zole
Unclear
Krohn
1986
285 n.r. n.r. Some
tested
(culture)
n.r. All tested
(culture)
0
(no pos-
itive cul-
ture)
All tested
(culture)
n.r. Single
dose sub-
lactam
+ amoxi-
cillin
Unclear
Larsson
1992
174 n.r. n.r. All tested
(culture)
0 (all ex-
cluded)
Some
tested
(culture)
n.r. All tested
(Amsel
criteria)
174
(100%)
Multi-
ple doses
metron-
idazole
No. ’23
excluded
because
of C. tra-
choma-
tis infec-
tion.’
64Perioperative antibiotics to prevent infection after first-trimester abortion (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 1. Testing and reporting of sexually transmitted infections and bacterial vaginosis (Continued)
Larsson
2000
1276 n.r. n.r. All tested
(n.r.)
0 (all ex-
cluded)
All tested
(n.r.)
0 (all ex-
cluded)
All tested
(Gram
stain)
220 (17.
2%)
Multi-
ple doses
clin-
damycin
No.’Ex-
clusion
criteria
in-
cluded..
. current
infection
with Tri-
chomonas
vaginalis,
C. tra-
chomatis,
N. gonor-
rhoeae or
vaginal
candidi-
asis.’
Levallois
1988
1077 n.r. n.r. All tested
(n.r.)
75 (7.
0%)
All tested
(n.r.)
0 (all ex-
cluded)
n.r. n.r. Multi-
ple doses
doxycy-
cline
No.
’Patients
infected
by N.
gonor-
rhoeae
were
excluded
before
ran-
domisa-
tion....
In phase
2 all
women
with
positive
chlamy-
dia
results
were
treated.’
Nielsen,
1993
1073 Asked
pre-op
308 Not
tested
Not
tested
All tested
(culture)
0 (all ex-
cluded)
n.r. n.r. Single
dose
Ofloxacin
No.
’Women
with pos-
itive cul-
tures for
N. gonor-
rhoeae
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Table 1. Testing and reporting of sexually transmitted infections and bacterial vaginosis (Continued)
were ex-
cluded.’
Sonne-
Holm
1981
493 Asked
pre-op
105 n.r. n.r. n.r. n.r. n.r. n.r. Multi-
ple doses
peni-
cillin +
pivampi-
cillin
Unclear
Sorensen
1992
378 Asked
pre-op
90 All tested
(im-
munoflu-
ores-
cence or
EIA)
27 (7.
1%)
All tested
(culture)
0 (all ex-
cluded)
n.r. n.r. Multiple
doses
ery-
thromycin
No.
’Women
with
a positive
gono-
coccal
cul-
ture were
treated
and ex-
cluded
from the
study.’
We-
strom
1981
212 n.r. n.r. n.r. n.r. All tested
(culture)
0 (all ex-
cluded)
All tested
(culture)
n.r. Sin-
gle dose
tinida-
zole
No.’
2 women
with
gonor-
rhoea
and 3
with tri-
chomo-
niasis
were ex-
cluded.’
Antibiotic prophylaxis vs. alternative regimen(s)
Caruso
2008
466 n.r. n.r. n.r. n.r. n.r. n.r. n.r. n.r. 5 days
prulifloxacin
vs. 3
days
prulifloxacin
Unclear.
STI test-
ing not
reported.
Heister-
berg
1986
81 Antibi-
otics for
PID
81 n.r. n.r. All tested
(culture)
0 (all ex-
cluded)
n.r. n.r. Multi-
ple doses
metron-
idazole
vs. mul-
No.
’Women
with pos-
itive cul-
tures
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Table 1. Testing and reporting of sexually transmitted infections and bacterial vaginosis (Continued)
ti-
ple doses
pivampi-
cillin
were
treated
before
the abor-
tion and
therefore
not in-
cluded.’
Lichten-
berg
2003
530 Asked
pre-op
18 Not
tested
Not
tested
Not
tested
Not
tested
n.r. n.r. 7 days
doxycy-
cline
vs. 3 days
doxycy-
cline
Yes. ’We
did not
take cer-
vical cul-
tures and
gave no
preoper-
ative
medica-
tion’
Screen-and-treat vs. universal antibiotic prophylaxis
Penney
1998
1613 n.r. n.r. All tested
(EIA)
91 (5.
6%)
All tested
(culture)
3 (0.2%) All tested
(Gram
stain)
282 (17.
5%)
Accord-
ing to
strategy
Yes.
Screen-
and-treat
vs
univer-
sal pro-
phylaxis
EIA - enzyme-linked immunoassay; n.r. - not reported
Table 2. Risk of bias as assessed in all 19 included trials
First author, year Adequate random se-
quence generation
Adequate allocation
concealment
Double-blind Incomplete outcome data ad-
dressed
Antibiotic prophylaxis vs. placebo
Crowley 2001 Yes Yes Yes Yes
Darj 1987 Yes Yes Yes Yes
Heisterberg 1985b Unclear Unclear Yes Yes
Heisterberg 1985c Yes Unclear Yes Yes
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Table 2. Risk of bias as assessed in all 19 included trials (Continued)
Heisterberg 1987 Yes Unclear Yes Yes
Heisterberg 1988 Yes Unclear Yes Yes
Krohn 1981 Yes Unclear Yes Unclear
Krohn 1986 Yes Unclear Yes No
Larsson 1992 Unclear Unclear Yes No
Larsson 2000 Yes Unclear Yes No
Levallois 1988 Yes Yes Yes No
Nielsen, 1993 Unclear Unclear Unclear No
Sonne-Holm 1981 Unclear Unclear Unclear No
Sorensen 1992 Yes Yes Yes Yes
Westrom 1981 Unclear Unclear Yes Yes
Antibiotic prophylaxis vs. alternative regimen(s)
Caruso 2008 Unclear Unclear Unclear Unclear
Heisterberg 1986 Yes Unclear Yes Yes
Lichtenberg 2003 Yes Yes Yes Yes
Screen-and-treat vs. universal antibiotic prophylaxis
Penney 1998 Yes Yes Yes No
Table 3. Exploration of heterogeneity by study and risk of bias in 15 trials comparing antibiotic prophylaxis vs. placebo
Characteristic No. of trials Heterogeneity Risk ratio according to statistical model
P value I2 (%) Fixed (95% CI)* Random (95% CI)† Random (95% PI) ‡
Overall
Overall 15 0.06 39 0.61 (0.52 to 0.73) 0.59 (0.46 to 0.75) 0.59 (0.30 to 1.14)
Universal antibiotic prophylaxis
No 10 0.07 43 0.68 (0.56 to 0.82) 0.66 (0.49 to 0.87) 0.65 (0.32 to 1.36)
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Table 3. Exploration of heterogeneity by study and risk of bias in 15 trials comparing antibiotic prophylaxis vs. placebo
(Continued)
Unclear 4 0.63 0 0.47 (0.31 to 0.73) 0.49 (0.32 to 0.75) 0.49 (0.19 to 1.26)
Antibiotic class
Nitroimidazoles 6 0.57 0 0.51 (0.35 to 0.73) 0.53 (0.37 to 0.77) 0.53 (0.31 to 0.77)
Tetracyclines 4 0.003 78 Data not pooled
Penicillins 2 0.85 0 0.52 (0.31 to 0.89) 0.52 (0.31 to 0.89) -
Antibiotic route
Oral 12 0.04 47 0.50 (0.49 to 0.71) 0.54 (0.40 to 0.74) 0.54 (0.24 to 1.24)
Timing of antibiotics
Preoperative 4 0.18 39 0.65 (0.46 to 0.90) 0.61 (0.39 to 0.98) 0.61 (0.12 to 3.11)
Peri-operative 6 0.02 62 0.58 (0.45 to 0.74) 0.48 (0.28 to 0.82) 0.48 (0.10 to 2.33)
Pre- and postop-
erative
4 0.24 29 0.70 (0.49 to 0.98) 0.67 (0.43 to 1.06) 0.67 (0.16 to 2.89)
Antibiotic regimen
Single dose 6 0.45 0 0.63 (0.50 to 0.80) 0.64 (0.51 to 0.82) 0.64 (0.46 to 0.90)
Multiple doses,
one day
3 0.02 73 0.26 (0.14 to 0.90) 0.28 (0.07 to 1.06) -
Multiple doses,
several days
6 0.27 22 0.71 (0.55 to 0.92) 0.70 (0.52 to 0.96) 0.70 (0.36 to 1.36)
Control group event rate ¶
< 12% 7 0.01 63 0.58 (0.45 to 0.75) 0.54 (0.34 to 0.85) 0.54 (0.14 to 2.09)
≥ 12% 8 0.45 0 0.64 (0.51 to 0.80) 0.66 (0.53 to 0.83) 0.66 (0.50 to 0.87)
Sequence generation
Adequate 10 0.06 45 0.53 (0.41 to 0.67) 0.51 (0.36 to 0.73) 0.51 (0.30 to 1.32)
Inadequate 5 0.29 19 0.72 (0.57 to 0.91) 0.71 (0.53 to 0.94) 0.71 (0.37 to 1.35)
Concealment of allocation
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Table 3. Exploration of heterogeneity by study and risk of bias in 15 trials comparing antibiotic prophylaxis vs. placebo
(Continued)
Adequate 4 0.04 64 0.42 (0.30 to 0.59) 0.40 (0.21 to 0.74) 0.40 (0.03 to 4.96)
Inadequate 11 0.39 5 0.70 (0.58 to 0.85) 0.71 (0.58 to 0.87) 0.71 (0.52 to 0.96)
Blinding
Adequate 13 0.05 43 0.57 (0.47 to 0.70) 0.55 (0.44 to 0.74) 0.55 (0.24 to 1.26)
Inadequate 2 0.22 33 0.71 (0.53 to 0.95) 0.69 (0.46 to 1.02) -
Incomplete outcome data addressed
Adequate 8 0.25 22 0.60 (0.47 to 0.78) 0.60 (0.44 to 0.82) 0.60 (0.32 to 1.13)
Inadequate 7 0.03 57 0.62 (0.50 to 0.78) 0.55 (0.37 to 0.78) 0.55 (0.18 to 1.72)
* Fixed-effect model, Mantel-Haenszel method;
† Random-effects model, Der Simonian Laird model, confidence interval using Mantel-Haenszel method;
‡ PI, prediction interval is the confidence interval of the approximate predictive distribution of a future trial, bas end on the extent of
heterogeneity;
¶ Variable dichotomised at median (12%)
Table 4. Meta-regression analysis of methodological characteristics
Characteristic No. of trials Ratio of risk ratios (95% CI)*
Random sequence generation
Adequate 10 1
Inadequate 5 1.29 (0.74 to 2.25)
Allocation concealment
Adequate 4 1
Inadequate 11 1.53 (0.88 to 2.68)
Blinding
Adequate 13 1
Inadequate 2 1.18 (0.59 to 2.37)
Incomplete outcome data addressed
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Table 4. Meta-regression analysis of methodological characteristics (Continued)
Adequate 8 1
Inadequate 7 0.98 (0.55 to 1.75)
* The ratio of risk ratios compares the effect size in trials that reported the feature inadequately with those that are reported adequately.
When greater than one, it means that the magnitude of effect was lower in the inadequate trials than the adequate ones.
A P P E N D I C E S
Appendix 1. Search strategies
We used the following search strategies to identify published studies in the following databases:
PUBMED
(abortion, induced OR pregnancy, trimester, first) AND (antibiotics OR antibiotic prophylaxis OR tetracyclines OR lactams OR
macrolides OR nitroimidazoles OR tinidazole OR quinolones OR oxolinic acid OR fluroquinolones)
EMBASE
(induced abortion or first trimester pregnancy) and (antibiotics OR antibiotic prophylaxis OR tetracyclines OR lactams ORmacrolides
OR nitroimidazoles OR tinidazole OR quinolones OR oxolinic acid OR fluroquinolones)
CENTRAL
abortion AND antibiotics
POPLINE
(abortion induced/pregnancy trimester first) & (antibiotics/“antibiotic prophylaxis”/tetracyclines/lactams/macrolides/ nitroimidazoles/
tinidazole/quinolones/“oxolinic acid”/fluroquinolones)
LILACS
abortion antibiotics prophylaxis
WH A T ’ S N E W
Last assessed as up-to-date: 10 June 2011.
Date Event Description
10 June 2011 Amended Review finalised, authors changed
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H I S T O R Y
Protocol first published: Issue 2, 2005
Review first published: Issue 3, 2012
Date Event Description
9 November 2009 Amended contact author changed
19 April 2008 Amended Converted to new review format.
3 January 2005 New citation required and major changes Substantive amendment
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
• Review uses the term ’post-abortal upper genital tract infection’, protocol uses ’post-abortal pelvic infection’.
• Review distinguishes between interventions that provide ’universal antibiotic prophylaxis’ without excluding those with genital
infections diagnosed before randomisation and ’antibiotic prophylaxis’, which refers to all other interventions in trials that stated that
women with specified laboratory or clinical diagnoses would be excluded. The protocol refers to universal antibiotic prophylaxis and
gives a definition of the types of antibiotics or strategy, but did not specify that women with genital infections at baseline should not
be excluded.
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